Urethral support system

Abstract
A urethral support system is described, including an introducer device and tissue implant. The introducer device may include a needle with multiple curves, some of the curves having multiple radii. A sheath assembly may be utilized to assist the passing of the tissue implant through a patient's tissue. The sheath assembly may include connectors configured to connect the sheath assembly to an end of the needle and a tab configured to detachably couple sheath sides over the tissue implant.
Description
BACKGROUND

An increasingly widespread technique for treating female urinary incontinence is that of sling suspension. Generally, sling suspension procedures involve the placement of a sling member beneath the patient's urethra. The sling member is preferably implanted in the patient's tissue by using an introducer needle to help draw the tissue implant sling into position. Examples of sling suspension procedures and devices are described, for example, in U.S. Pat. Nos. 5,112,344, 5,899,909, 6,273,852 and U.S. Patent Application Publication No. 2006/0015069, each of which is incorporated by reference in its entirety in this application.


Slings have been made from numerous materials, including both synthetic and natural, and are generally in the form of a mesh. A traditional sling procedure involves placing a strip of an implant material (natural tissue or synthetic mesh) under the urethra and securing it to the rectus fascia or other portions of the patient's anatomy with sutures to hold the implant in position during the healing process.


Recently, however, improved techniques have been developed that speed the implant process by reducing the number of incisions made and altering the pathways by which the tissue implant is introduced into the body. These improvements, which employ specialized instrumentation, help to reduce operative time and have made the procedure less invasive. The improved techniques generally require that an implant be joined to an introducer needle. The implant is then inserted into, and pulled through the body. Subsequently, the implant is detached from the introducer needle. One deficiency with existing introducer devices, however, is that they are typically unwieldy, awkward and time consuming to attach and/or detach to an implant to or from an introducer device.


Applicants have recognized that it would be desirable to provide urethral support systems, including various needle configurations and components, to facilitate the introduction of implants into a body and to provide users with quick and easy identification of components during implantation. Applicants have also recognized that it would be desirable to provide packaging for urethral support systems that would convey to the user exactly what components are enclosed and the type of procedure for which the components are best suited. Thus, described herein are embodiments of urethral support systems and methods of use.


SUMMARY

Accordingly, various embodiments of urethral support systems are described herein. It should be understood that although this disclosure describes the sling suspension of the female urethra, the invention is not to be limited thereto. By way of non-limiting example, it has been determined that the devices and techniques described herein could be modified to support other body organs such as the bowel or bladder. Consequently, all portions of this description should be understood to encompass alternative uses of the embodiments described.


In one embodiment, an introduction device for an implant includes a handle, a first plane bisecting the handle between a top and bottom thereof along a longitudinal axis, and an elongate member having a proximal end including a straight segment coupled to the handle and a distal end terminating in a tip, the elongate member including a first portion defining a first curve and a second portion defining a second curve lying in a second plane perpendicular to the first plane. In another embodiment, an introducer needle includes a proximal section including a feature that enables engagement with a handle, a distal section, and an intermediate section disposed between the proximal and distal sections, the needle including, from a proximal end to a distal end thereof, a straight section, a first curved section, a second curved section having a radius greater than the first curved section, and an introducer tip.


In another embodiment, a kit for introducing an implant includes a first introduction device, including a first handle having a length extending along a longitudinal axis and a first elongate member having a proximal end coupled to a distal end of the handle, the first elongate member including a first curved portion terminating in a tip, the first curved portion lying in a plane perpendicular to the longitudinal axis, a path along the first curved portion from a proximal end to a distal end thereof traveling in a first direction, and a second introduction device, including a second handle having a length extending along a longitudinal axis and a second elongate member having a proximal end coupled to a distal end of the handle, the second elongate member including a second curved portion terminating in a tip, the second curved portion lying in a plane perpendicular to the longitudinal axis, a path along the second curved portion from a proximal end to a distal end traveling in a second direction opposite the first direction.


In one embodiment, a sheath assembly includes a mesh implant, a first section disposed over the first side of the mesh implant, a proximal end of the first section including a first extension forming an angle with respect to a body of the first section in a delivery configuration, a second section separate from the first section disposed over a second side of the mesh implant, a proximal end of the second section including a second extension forming an angle with respect to a body of the second section in the delivery configuration, the first section body and second section body together covering substantially the entire mesh implant in the delivery configuration, and a tab configured for attachment to the first and second extensions.


In another embodiment, a handle for an elongate member includes a core, including a cavity with a first opening in a first side of the core and a channel with a second opening in a distal end of the core, the channel connecting the second opening and the cavity, a skin covering the core, and a locking mechanism configured to at least temporarily secure an elongate member, having a section positioned in the cavity, to the handle.


In still another embodiment, an introduction device for an implant includes an elongate member including a curved portion, and a handle including a body, having a distal end with an opening configured to receive a proximal section of the elongate member and a proximal end including an alignment feature, and a locking mechanism configured to at least temporarily secure the elongate member to the handle.


These and other embodiments, features and advantages will become more apparent to those skilled in the art when taken with reference to the following more detailed description of the invention in conjunction with the accompanying drawings that are first briefly described.





BRIEF DESCRIPTION OF THE DRAWINGS


FIG. 1A is a perspective view of an introducer device having an introducer needle attached to a handle.



FIG. 1B is a front view of the introducer device of FIG. 1A.



FIG. 1C is a side view of the introducer device of FIG. 1A.



FIG. 1D is a side view of the introducer needle of FIG. 1A without the handle.



FIG. 1E is a partial view of the introducer needle of FIG. 1D.



FIG. 1F is a partial side view of the introducer needle of FIG. 1D showing a distal section and a needle tip.



FIG. 2A is a perspective view of another embodiment of an introducer device having an introducer needle attached to a handle.



FIG. 2B is a front view of the introducer device of FIG. 2A.



FIG. 2C is a side view of the introducer device of FIG. 2A.



FIG. 2D is a side view of the introducer needle of FIG. 2A without the handle.



FIG. 2E is a partial view of the introducer needle of FIG. 2D.



FIG. 2F is a partial side view of the introducer needle of FIG. 2D showing a distal section and a needle tip.



FIG. 3 is a side view of another embodiment of an introducer needle.



FIG. 4 is a side view of a further embodiment of an introducer needle.



FIG. 5 is a side view of yet another embodiment of an introducer needle.



FIG. 6 is a top view of an embodiment of an introducer handle.



FIG. 7A is a top view of another embodiment of an introducer handle.



FIG. 7B is a back view of the introducer handle of FIG. 7A.



FIG. 7C is a perspective view of the introducer handle of FIG. 7A.



FIG. 7D is a further back view of the introducer handle of FIG. 7A.



FIG. 7E is a side cross-sectional view of the introducer handle of FIG. 7D, along the lines 7E-7E.



FIG. 8A is a partial perspective view of a sheath assembly in an unassembled configuration.



FIG. 8B is a partial perspective view of a sheath assembly in an assembled configuration.



FIG. 8C is a top view of a sheath side of a sheath assembly.



FIG. 9A is a top view of a sling tube of a sheath assembly.



FIG. 9B is a perspective exploded view of various components of a sheath assembly connection.



FIG. 9C is a perspective view of FIG. 9B with the sheath assembly components connected.



FIG. 10A is a perspective view of a sheath assembly connector.



FIG. 10B is a top view of the sheath assembly connector of FIG. 10A.



FIG. 10C is a cross-sectional view of the sheath assembly connector of FIG. 10B, across the line 10C-10C.



FIG. 11A is an exploded view of one embodiment of an internal packaging configuration.



FIG. 11B is an exploded view of another embodiment of an internal packaging configuration.



FIG. 12A is an illustration of one embodiment of an outer packaging configuration.



FIG. 12B is an illustration of another embodiment of an outer packaging configuration





DETAILED DESCRIPTION

The following detailed description should be read with reference to the drawings, in which like elements in different drawings are identically numbered. The drawings, which are not necessarily to scale, depict selected embodiments and are not intended to limit the scope of the invention. The detailed description illustrates by way of example, not by way of limitation, the principles of the invention. This description will clearly enable one skilled in the art to make and use the invention, and describes several embodiments, adaptations, variations, alternatives and uses of the invention, including what is presently believed to be the best mode of carrying out the invention.


As used herein, the terms “about” or “approximately” for any numerical values or ranges indicate a suitable dimensional tolerance that allows the part or collection of components to function for its intended purpose as described herein. Also, as used herein, the terms “patient”, “host” and “subject” refer to any human or animal subject and are not intended to limit the systems or methods to human use, although use of the subject invention in a human patient represents a preferred embodiment. In addition, as used herein, the term “plane” has its ordinary mathematical meaning, including referring to a surface containing all the straight lines that connect any two points on it.


Generally speaking, in accordance with the invention, an implant system involving a needle connector and implant is provided to overcome disadvantages of existing systems. First, it should be understood that although this disclosure speaks of the sling suspension of the female urethra, this invention is not to be limited thereto. By way of non-limiting example, it has been determined that the devices and techniques described herein could be modified to support other body organs such as the bowel or bladder. Consequently, all portions of this description should be understood to encompass such alternative uses of this invention.


As depicted in FIGS. 1A, 1B and 1C, an introducer device 110 is shown in accordance with various embodiments. As is discussed in further detail below, introducer device 110 may be used to introduce an implant strip, such as, for example, a tissue implant, into a patient. Introducer device 110 includes an introducer handle 112, which is shown attached to an introducer needle 114 with a portion in the shape of a halo. As will be discussed in further detail below, the configuration of the halo needle 114 allows a doctor to insert an implant strip or tissue implant into the patient while navigating around and through various organs and/or other structures within the body of the patient.


The halo needle 114 may be permanently or selectively attached to a handle, but in a preferred embodiment, the halo needle 114 is permanently attached to a handle (e.g., by molding the handle 112 over a proximal end of the needle 114). As shown in FIG. 1D, the halo needle 114 can have a straight segment 116 located at a proximal portion of the halo needle 114. A handle engagement portion 117 of the straight segment 116 can be coupled to the handle 112, as shown in FIGS. 1A, 1B and 1C. Adjacent the straight segment 116 is a first curved portion 118 followed by a second curved portion 120. A needle tip 124 can be located at a distal end 126 of the halo needle 114.


With reference FIG. 1C, the straight segment 116 and handle 112 lie substantially along a first plane 100. The second curved portion 120 lies along a second plane 102, which is substantially perpendicular to the first plane 100. As seen in FIG. 1B, when the halo needle 114 is connected to the handle 112, the first plane 100 bisects the handle along its longitudinal axis. The portion of the handle above the first plane 100 is defined as a top handle portion 128 and the portion below the first plane 100 is defined as a bottom handle portion 130. In addition, the first curved portion 118 lies substantially below the first plane 100 and connects with the second curved portion 120 below the first plane 100 at a distance L1. In one embodiment, the distance L1 is approximately 0.310 inches. As best seen in the bottom view of the halo needle 114 shown in FIG. 1D, the first curved portion 118 can also diverge relative to a third plane 104, which is perpendicular to the first plane 100 and the second plane 102, at an angle Θ1 of approximately 20 degrees.


The second curved portion 120 can also be asymmetrical with respect to the third plane 104, as best seen in FIG. 1E. The second curved portion 120 can include a first arc 122 extending from a proximal end of the second curved 120 to the third plane 104 and a second arc 123 extending from the third plane 104 to a distal end of the second curved portion 120. In one embodiment, the first arc 122 has a radius of curvature R1 that is greater than a radius of curvature R2 of the second arc 123. For example, in one embodiment, the radius of curvature R1 is approximately 1.44 inches and the radius of curvature R2 is approximately 1.06 inches.


With further reference to FIG. 1E, a first length L2 measured along a straight line in the second plane 102 (second plane 102 is depicted in profile in FIGS. 1C and 1D) from the proximal end of the second curve 120 to the third plane 104 can be greater than a second length L3 measured along a straight line in the second plane 102 from the third plane 104 to the distal end of the second curve 120. In one embodiment, the first length L2 is approximately 1.40 inches and the second length L3 is approximately 1.10 inches. The distal end 126 of the halo needle 114 also can be substantially parallel to the third plane 104, as best seen in FIG. 1B. In addition, as depicted in FIG. 1A, the first curved portion 118 can have a substantially uniform radius of curvature R3. In one embodiment, R3 is about 4.44 inches.


The first curved portion 118 and the second curved portion 120 can be connected at a transition region 132, as best seen in FIGS. 1A and 1E. In one embodiment, the transition region 132 has a radius of curvature R4 of approximately 0.12 inches. Furthermore, the first curved portion 118 can be connected the straight segment 116 at a second transition region 134, as best seen in FIG. 1D. In one embodiment, the second transition region 132 has a radius of curvature R5 of approximately 1.00 inch.


In general, it has been found that the shape of the halo needle 114 provides several benefits. For example, the curvature of the halo needle 114 has been found to provide easier passage while navigating around and through various organs and/or other structures within the body of the patient. The curvature of the halo needle 114 has also been found to allow easier rotation and exteriorization of the needle tip 124. In addition, the curvature of the halo needle 114 can provide an axis of rotation at a mid-point of the device 110, which can advantageously mimic a helical rotation.


Other dimensions of the introducer needle 120 have also been found to be beneficial in accordance with one embodiment. With reference to FIG. 1D, the straight segment has a length L4 measured along a straight line in the first plane from its proximal end to its distal end of about 3.75 inches and the halo needle 114 has a length L5 measured along a straight line in the first plane from the introduction needle's proximal end to the second plane 102 in the range of about 7.25 inches to about 7.50 inches, preferably approximately 7.37 inches. Referring to FIG. 1C, when the handle 112 is attached to the halo needle 114, a length L6 measured along a straight line in the first plane 100 from a proximal end of the handle 112 to the second plane 102 is in the range of about 8 inches to about 9 inches, preferably approximately 8.76 inches. In addition, a length L7 measured along a straight line of the first plane from a distal end of the handle 112 to the second plane 102 is in the range of about 3 inches to 4 inches, preferably approximately 3.87 inches.



FIG. 1F illustrates the introducer needle distal end 126 and the needle tip 124. The tip 124 has a tapered portion 136 with a frusto-conical shape connected to a shaft portion 138 with a cylindrical shape. The shaft portion 138 is connected to a barb 140. The barb 140 has a generally flat part 142 and a front part 144 having semi-spherical shape. The shape of the needle tip 124 has been found to have several benefits, including providing easier insertion and passage, having a smaller profile, and being less sharp than other devices. Certain dimensions for the configuration of the tip 124 have been found to be beneficial in accordance with one embodiment. With reference to FIG. 1F, the tapered portion 136 is tapered at an angle Θ2 of about 11 degrees and has a length L8 of about 0.164 inches. The shaft portion 138 has a longitudinal length L9 of about 0.090 inches. The barb 140 has longitudinal length L10 of about 0.060 inches and a maximum thickness L11 in the range of about 0.068 inches to about 0.072 inches, preferably approximately 0.070 inches. The front part 144 of the barb has a radius of curvature R6 in the range of about 0.030 inches to about 0.040 inches, preferably approximately 0.035 inches.



FIGS. 2A-2C show an introducer device 210 including an introducer needle 214 with a portion in the shape of a halo attached to a handle 212. FIGS. 2D and 2E show the halo needle 214 without an introducer handle. FIG. 2F shows a distal portion of the halo needle 214 and a needle tip 224. In one embodiment, the introducer device 210 has the same shapes and dimensions as the introducer device 110 shown in FIGS. 1A-1F and discussed above, but the halo needle 214 curves in the opposite direction as the halo needle 114. For example, if introducer devices 110 and 210 were placed side-by-side (with handles adjacent to one another), either the proximal end of the second curved portion of halo needle 214 would be adjacent the proximal end of the second curved portion of halo needle 114 or the distal end of the second curved portion of halo needle 214 would be adjacent the distal end of the second curved portion of halo needle 114. As will be explained in more detail below, the introducer device 110 and the introducer device 210 can be beneficially used in the same procedure. For example, the introducer device 110 can be used on one side of a patient and the introducer device 210 can be used on the other side of the patient. By doing so, the procedure can be performed in a more beneficial manner. As with the halo needle 114, the halo needle 214 may be permanently or selectively attached to a handle, but in a preferred embodiment, the halo needle 214 is permanently attached to a handle (e.g., by molding the handle 112 over a proximal end of the needle 214).


With reference to FIG. 3, there is shown another embodiment of an introducer needle, hook needle 310. The hook needle 310 can be used to perform various surgical procedures, including a transobturator implant deliver procedure. The hook needle 310 can include a first straight segment 316 at its proximal end, a second straight segment 318 connected to the first straight segment 316 via a transition area 314, and a curved portion 320. A tip 324 is then connected to curved portion 320 at a distal end of the hook needle 310. The first straight segment 316 can also include a handle engagement portion 317 configured to attached to a handle, such as one of the handles described herein. As shown in FIG. 3, the hook needle 310 can lie along a single plane (not shown). Preferably, the hook needle 310 is permanently attached to a handle, such as handle 612, through a molding process.


Certain dimensions for the configuration of the hook needle 310 have been found to be beneficial in accordance with one embodiment. The straight segment 316 can have a longitudinal length L12 of about 4.25 inches and the handle engagement portion 317 can have a longitudinal length L13 of about 3.50 inches. The transition region 334 can have a radius R7 of about 0.25 inches. The second straight segment 318 can have a length L14 of about 0.64 inches. The curved portion 320 can have a radius R8 of about 1.41 inches. The tip 324 can have the same dimensions as the tip 124 described above with reference to FIG. 1F. An angle Θ3 of the tip 324 relative to the first straight segment 316 can be about 75 degrees.


With reference to FIG. 4, there is shown another embodiment of a needle 410 for an introducer device including a handle (e.g., handle 712 in FIG. 7A). The needle 410 can be used in various surgical procedures, including a suprapubic implant delivery procedure. The needle 410 can include a straight segment 416 at its proximal end. A curved portion 420 can be connected at a distal end of the straight segment 416. A tip 424 can be connected to a distal end of the curved portion 420. The tip 424 can be similar or the same as the tip 24 described with reference to FIG. 1F. The straight segment 416 can also include a handle engagement portion 417 configured to be attached to a handle, such as one of the handles disclosed herein. As shown in FIG. 4, the needle 410 can lie along a single plane. Certain dimensions for the configuration of the needle 410 have been found to be beneficial in accordance with one embodiment. The straight segment 416 can have a length L15 in the range of about 4.36 inches to about 4.48, preferably approximately 4.42 inches and the handle engagement portion 317 can have a length L16 in the range of about 3.25 inches to about 3.75 inches, preferably approximately 3.50 inches. The curved portion 320 can have a radius R9 of about 4.75 inches. The tip 424 can have the same dimensions as the tip 124 described above with reference to FIG. 1F. An angle Θ4 of the tip 424 relative to the first straight segment 416 can be about 108 degrees.


With reference to FIG. 5, there is shown yet another embodiment of a needle 514 for use with a introducer device including a handle (e.g., handle 712 in FIG. 7A). The needle 514 can be used in various surgical procedures, including a retropubic implant delivery procedure. A needle tip 524 is located at a proximal end of the needle 514. Connected to the needle tip 524, is a straight segment 516 followed by a curved segment 520. A beveled tip 522 is located at a distal end of the needle 514. In one embodiment, the beveled tip 522 is inserted through a patient, where the bevel assists in dissecting through the tissue. Once passed, a handle, such as one of the handles described herein, can be removed from a proximal end of the needle 514, and the tip 524 can then be attached to a tissue implant. Exemplary surgical techniques using the needle 514 are described in more detail further below. Certain dimensions for the configuration of the needle 514 have been found to be beneficial in accordance with one embodiment. The straight segment 516 can have a length L17 in the range of about 4.36 inches to 4.48 inches, preferably approximately 4.42 inches and the handle engagement portion 517 can have a length L18 in the range of about 3.25 inches to about 3.75 inches, preferably approximately 3.50 inches. The curved portion 520 can have a radius R10 of about 3.1 inches. The angle Θ5 of the beveled tip 522 relative to the straight segment 516 can be about 90 degrees. The beveled tip 522 can have a length of about 1 inch. The tip 524 can have the same dimensions as the tip 124 described above with reference to FIG. 1F. The needle 514 can lie along a single plane, where the length L19 measured in a straight line from the tip 524 to the tip 522 can be in the range of about 7.50 inches to about 8.00 inches, preferably approximately 7.69 inches and the length L20 can be in the range of about 4.15 inches to about 4.50 inches, preferably approximately 4.27 inches.


A top view of one embodiment of an introducer handle 612 attached to an introducer needle 614 is shown in FIG. 6. The introducer handle 612 can have an opening 660 at its distal end to attach to the proximal end of the introducer needle 614. An operator of an introducer device can grasp the handle 612 for performing a procedure. The exterior of the handle can also have textured elastomer material for providing an improved grip and appearance. In one embodiment, the handle 612 is similar to, or the same as, handle 112 described above, and may be used with halo needles or hook needles during trans-obturator procedures.



FIGS. 7A-7B show another embodiment of an introducer handle 712 attached to an introducer needle 714. Handle 712 can be used in various surgical procedures, for example during a retropubic or suprapubic procedure. In addition, the introducer handle 714 can be selectively attached to, and detached from one or more of the introducer needles described herein, as well as with other introducer needles known in the art. With further reference to FIG. 7A, the introducer handle 712 can have an opening 760 at its distal end to attach to the proximal end of the introducer needle 714. The handle 712 also has a pushbutton 762 located on one side of the handle 612. Gripping depressions 764 and 766 can be formed in the handle 712 for providing for better gripping of the handle 712 during a surgical procedure.



FIG. 7B shows an artificial horizon 780 feature formed on a back side of the handle 712 in accordance with one embodiment. As used herein, the term “artificial horizon” can refer to a visual indicator that aids a user in navigating the device through a patient, for example. In other words, an artificial horizon can provide a user with visual directional aid during a needle passage. In the embodiment shown in FIG. 7B, the artificial horizon 780 includes a cross-hair pattern formed on a back side of the handle 714. By viewing the position of the artificial horizon 780 relative to another object, a user can determine, for example, the rotation of a needle attached to the handle 712 relative to the other object.



FIG. 7C shows a side perspective view of the handle 712, FIG. 7D shows a back view of the handle 712, and FIG. 7E is a side cross-sectional view of the handle 716 along the line 7E-7E shown in FIG. 7D. With reference to FIG. 7D, the handle 712 includes a core 781 with an interior portion defining a cavity 772 and an axial channel 770. The axial channel 770 extends from the opening 760 in the distal end of the handle, through a proximal side of the cavity 772, out a distal side of the cavity 772, and ending at a stop pin 774. A skin material 782 can cover all or just a portion of the core 781. The skin material 782 can be a textured elastomeric material for providing improved gripping and appearance. In addition, a locking mechanism 784 is positioned in the cavity 772. The locking mechanism 784 is configured to at least temporarily secure a proximal end of an elongate member, such as an introducer needle, to the handle 712. In the embodiment shown in FIG. 7E, the locking mechanism 784 includes a retainer 776, a spring 778 positioned under the retainer 776, and a pushbutton 762 positioned in a top opening of the cavity 772 and connected to the retainer 776.


The retainer 776 is positioned between the spring 778 and pushbutton 762 and in one embodiment is shaped like a bracket, including an opening in a side adjacent the proximal side of the cavity 772. The opening may be shaped like an inverted teardrop with the large portion of the teardrop shape adjacent the pushbutton (or top of the cavity 772) and the small portion of the teardrop shape adjacent the spring (or bottom of the cavity 772). The pushbutton 762 is biased in a closed position by the spring 778, such that to insert a needle portion into (or through) the chamber requires depression of the pushbutton 762, which in turn moves the retainer 776 so that the large portion of the teardrop shape (or other shaped opening of the retainer) is in-line with the channel 770 and passage of a needle into or through the chamber is permitted. Release of the pushbutton 762 causes the spring 778 to move the retainer 776 upward so that the small portion of the teardrop shape is coincident with the channel 770. Thus, a needle portion inserted into or through the cavity 772 will be tightly gripped by the retainer 776, preventing axial movement thereof.


To further enhance the engagement between the retainer and the needle inserted into or through the cavity 772, the needle may be configured with a notch or other engagement feature, such as the circumferential notches 418 and 518 on needles 410 and 510, respectively (FIGS. 4 and 5). With respect to the needles 410 and 510, the notches 418 and 518 may be spaced a distance from the proximal end of the needle such that when the proximal end is inserted through the cavity 772 and into contact with the stop pin 774, the notches 418 and 518 are aligned with a side wall of the retainer (on either side of the cavity 772). Moreover, the notches may have a thickness at least slightly greater than the thickness of the retainer side wall such that the portion of the side wall engaging the needle (e.g., the inner edge of the opening) is received within the notch.


In accordance with one embodiment, an introducer needle, such one of the introducer needles described above, can be selectively attached and detached from the handle 712. To attach an introducer needle to the handle 712, a proximal end of the introducer needle is inserted into the opening 760 and pushed through the axial channel 760 and the retaining chamber 772 until the proximal end hits the stop pin 774. The introducer needle can be selectively detached from the handle 712 by pressing the button 762 and pulling the needle proximal end out of the axial channel 760. It is understood that other types of locking mechanisms known in the art can also be used.


Various features of a sheath assembly 800 are described with reference to FIGS. 8-9. The sheath assembly 800, in one embodiment, includes two sheath sides, two sling tubes, a sheath tab and two connectors, each of which are described in more detail below. FIG. 8A is a partial view of a first sheath side 802a and a second sheath side 802b, both of which make up a portion of the sheath assembly 800. In one embodiment, the first sheath side 802a is very similar or identical to the second sheath side 802b. The sheath sides are preferably made of a material with a low coefficient of friction, such as polytetrafluoroethylene (PTFE). A first side of a mesh implant (not shown) can be disposed inside the first sheath side 802a and a second side of the mesh implant (not shown) can be disposed inside the second sheath side 802b. A proximal end of the first sheath side 802a has a first extension 804a forming an angle Θ6 with respect to a body of the first sheath side. Similarly, a proximal end of the second sheath side 802b has a second extension forming an angle Θ7 with respect to a body of the second sheath side when placed in a delivery configuration. As manufactured, the extensions 804a, 804b may be parallel extensions of their respective sheath sides, such that they need to be manually bent or configured into angles Θ6, Θ7. Alternatively, the extensions 804a, 804b may be manufactured with pre-fashioned angles Θ6, Θ7. In one embodiment, angles Θ6 and Θ7 are each approximately 90 degrees.


The sheath assembly is shown in a delivery configuration in FIG. 8B, in which a tab 806 is attached to the first and second extensions 802a and 802b. In one embodiment, the tab 806 includes a slot 808 configured to permit sliding of the first and second extensions 802a and 802b therethrough, as shown in FIG. 8A. The tab 806 may include an adhesive on at least a portion of an inner surface thereof to facilitate adhesion of the tab 806 to the extensions 802a and 802b or to itself. The tab 806 can also be heat-sealed over the extensions 802a and 802b. In one embodiment, the tab 806 is made of Tyvek®, which is commercially available from DuPont, Inc. In addition, the tab 806 can have a visual indicator. As seen in FIGS. 8A and 8B, the visual indicator can be arrows 810a and 810b on opposing sides of the tab 806. In one embodiment, the tab 806 has a color to match the color of the sheath assembly, handle, or other features of the introducer kit. In one embodiment, a portion 812 of the tab 806 can be offset for providing easy gripping of the tab 806 and peeling apart the tab 806. FIG. 8C shows the sheath side 802 with the extension 804 in the manufactured straight configuration (as opposed to the angled configuration shown in FIGS. 8A and 8B).


Certain dimensions of the sheath side 802 have been found to be beneficial in accordance with one embodiment. With reference to FIG. 8C, a length L21 of the second extension can be about 0.50 inches and the width L22 of the second extension can be about 0.4 inches. The length L23 of the sheath side can be about 10.0 inches and the length L24 of the tapered section can be about 1.0 inch. The length L25 of the coupling section can be about 0.50 inches.


With reference to FIG. 9A, a distal section of the sheath side 802 can include a tapered section 814 connected to a coupling section 816 for attachment to a sling tube 900. In one embodiment, distal and proximal ends of the sling tube 900 can have respective reduced diameter sections 902a and 902b, each reduced diameter section 902a and 902b configured to be inserted into one of the coupling section 816 and a needle connector, for example. In another embodiment, only one end (e.g., 902a) of the sling tube 900 has a reduced diameter section for insertion into coupling section 816, while the other end (e.g., 902b) has the same diameter as the body of the sling tube 900 for receipt of a connector end, such as connector stem 1006, discussed in more detail below. In one embodiment, the sling tube 900 has a length L26 of about 8.0 inches (8 to 9 inches preferably), and the reduced diameter section 902 has a length L27 of about 0.75 inches.



FIGS. 9B and 9C illustrate a connection between the sheath side 802 and the sling tube 900 in accordance with one embodiment. A rod 904 (e.g., made of stainless steel) can be inserted into one of the reduced diameter sections 902. The reduced diameter section 902 can then be inserted into the coupling section 816 of the sheath side 802. With reference to FIG. 9D, a crimp 906 can be swaged around the area between the coupling section 816 and the sling tube 900. In one embodiment, prior to assembling this section of the sheath assembly 800, a primer is applied to the inner diameter of the coupling section and adhesive is applied to the outer diameter of the reduced diameter section for providing a secure connection. The sling tube 900 may be of a different color than the sheath to provide a clear indication to the surgeon during cytoscopy where the sheath side 802 ends and the sling tube 900 begins. In one embodiment, the sling tubes 900 of a sheath assembly 800 are similar in color to other features of the sling assembly and/or packaging for the introducer kit as described herein. For example, in one embodiment, the sling tubes 900 have a green color, along with the sheath tab 806, and the packaging for the introducer device used therewith (e.g., the introducer device 110 and 210), while the sheath sides (e.g., made of PTFE) are clear (e.g., transparent) so that the mesh implant can be seen.


As described above, a tissue implant or support strip can be secured to an introducer needle for introducing the tissue strip of support strip into a patient, for example. In accordance with various embodiments, a connector may be used to facilitate connection between a tissue implant and an introducer needle. Advantageously, a connector can provide selective attachment and detachment of implants to and from an introducer needle.


With reference to FIGS. 10A-10C, there is shown an embodiment of a sheath assembly connector 1000. Connector 1000 has a proximal end 1002 and a distal end 1004. Proximal end 1002 is designed for connecting to an introducer needle, such as the introducer needles described herein, and the distal end 1004 includes a stem 1006 designed for insertion into a receiving member. For example, the distal end 1004 can be inserted into the end of the sling tube 900 opposite the end attached to the sheath side 802. The stem 1006 projects from a main body 1008 and a barb 1010 is located at the distal end of the stem 1006. The barb 1010 and all or a portion of the stem 1006 can be inserted into a corresponding opening of a sheath or other member coupled to the tissue implant. For example, the distal end 1004 of the connector 1000 can be inserted into an end of the tube 900 and a crimp swaged over the tube and distal end to secure the connector 1000 to the tube 900.


With reference FIG. 10C, the main body 1008 includes a cavity 1012. The cavity 1012 can be sized and shaped to be approximately equivalent to the size and shape of a needle tip. Accordingly, an opening 1014 can be located on one side of the cavity 1012 and a semi-spherical shaped portion 1016 located on the other side, a tapered lumen section 1018 located between the opening 1014 and the semi-spherical shaped portion 1016. The semi-spherical shaped portion 1016 can be approximately equivalent to the shape of a needle tip. With reference to FIG. 10A, the connector 1000 can also have various cutout sections. For example, side cutouts 1020 and 1022 can be provided, with respective identical cutouts located on the opposite side of the connector 1000. The cutouts 1010 and 1022 can be designed to provide detectable feedback to a user. For example, the connector 1000 can provide one or more clicking noises to notify a user that the needle has been properly inserted into the connector 1000.


The tissue connector 1000 may be quickly and easily attached or coupled to an introducer needle by inserting a needle tip of an introducer needle into the cavity 1008 of the tissue connector 1000. The tissue connector 1000 can also be quickly and easily removed from the introducer needle by pulling the connector 1000 off of and away from the end of the introducer needle such that the needle is removed from the cavity 1008 of the connector. A benefit of such a design, whereby the tissue connector 1000 may be easily and quickly attached to an introducer needle or removed therefrom, is that it facilitates easy placement of the tissue implant to the needle and thus speeds up the implanting procedure as will be described in further detail below. The connector 1000 may be made of a polypropylene material to facilitate removal of the needle. Alternatively, or following removal of the needle, the tube (or other component attached to the needle) may be severed proximal of the connector attachment point to permit the surgeon to insert the needle tip into the tube for an additional pass through the tissue. In a preferred embodiment, the tube is configured with dimensions to provide a friction fit with the needle tip for such a procedure.


In one embodiment, the tissue connector 1000 has a profile (e.g. outside diameter) such that a generally constant diameter is provided from the connector 1000 to a member to which it is attached, such as the sling tube 900. Such a profile can reduce drag when pulling the needle and tube through a patient's tissue.


Certain dimensions for the configuration of the tissue connector 1000 have been found to be beneficial in accordance with various embodiments. With reference to FIG. 10B, the length L28 of the stem 1006 and barb 1010 can be about 0.350 inches. The barb 1010 can have a large diameter L29 of about 0.017 inches, and a length L30 of about 0.076 inches. A tapered portion 1024 of the barb 1010 has an angle Θ8 in the range of about 28 degrees to about 32 degrees, preferably about 30 degrees. With reference to FIG. 10C, the total length L31 of the connector 1000 can be in the range of about 0.67 inches to about 0.71 inches, preferably about 0.69 inches, and the main body 1008 can have a length L32 of about 0.34 inches. The tapered lumen section 1018 can have a length L33 of about 0.24 inches and be tapered at an angle Θ9 of about 7.5 degrees. A neck area 1026 located where the lumen section 1018 and the semi-spherical portion 1016 connect can have an interior diameter L34 of about 0.050 inches.


In one embodiment, various needles, handles, and sheath assembly components are included in a kit for placing a sling suspension in a body, for example under a female urethra. The kit may be packaged in a box including introducer devices for a particular procedure (as described below), as well as a sheath assembly including a mesh implant, as described herein. The packaging may include internal packaging with a single tray design, such as shown in FIGS. 11A and 11B, including a retainer tray used to house the sheath assembly and hold the needles in place (FIG. 11A). FIG. 11A shows one side of the tray design, while FIG. 11B shows the opposite side (i.e., upside down from FIG. 11A). Certain needles described herein are shown combined together in the trays of FIGS. 11A and 11B, although this is for illustrative purposes and shows only two potential packaging embodiments for an introducer system as contemplated herein.



FIGS. 12A and 12B illustrate further embodiments of packaging for the introducer system described herein, showing a box in which the trays are housed. Notable on the boxes or outer packaging is the use of easily identifiable watermarks that quickly impart to the user which needle introduction system is held therein, as well as descriptors (e.g., letters or symbols) to indicate the procedure for which the product is suitable. For example, with respect to letter descriptors indicating the type of procedure for the introducer system in the package, the letter “R” could represent a retropubic system, the letter “S” could represent a suprapubic system, the letters “RS” could represent both retropubic and suprapubic systems, and the letters “TO” could represent a trans-obturator system (e.g., hook needle 310, halo needles 114 and 214, or a combination thereof). Also notable is the use of a particular color on the outer packaging (e.g., green) to match other features of the introduction system (e.g., sling tubes, sheath tab, etc.) for branding purposes, the use of silhouette images to show the configuration of one or more of the devices held in the packaging, and directional arrows to indicate the direction the needles are to be introduced between a suprapubic and retropubic procedure (FIG. 12A).


Numerous configurations are possible for packaging of introducer systems, kits or devices. For instance, one configuration shown in FIG. 12A is a retropubic kit including, for example, two retropubic handles (e.g., handles 712) with two needles (e.g., needles 514) and a sheath assembly (e.g., sheath assembly 800). The needles may be pre-inserted into the handles. Other examples include a suprapubic kit (e.g., with two suprapubic needles 410 with handles 712 and sheath assembly 800), a retropubic/suprapubic kit (e.g., two handles 712, two retropubic needles 514, two suprapubic needles 410, and a sheath assembly 800), a TO hook kit (e.g., two hook needles 310 with handles 112 permanently molded thereon and a sheath assembly 800), a TO halo kit (e.g., two introducer devices 110, 210 and a sheath assembly 800), and a TO combination kit (e.g., two hook needles 310 with handles 112 permanently molded thereon, two introducer devices 110, 210, and a sheath assembly 800). Of course, other packaging configurations including devices and components described herein are also within the scope of the invention.


EXAMPLES OF SURGICAL PROCEDURES

Several methods are contemplated herein. Although the methods of use as disclosed herein generally relate to female incontinence conditions and treatments/procedures, male incontinence conditions and treatments/procedures are also included within the scope of the present invention. Further, the term “urethra,” with respect to sling positioning, is used for brevity and reader convenience. It should be noted that the embodiments described herein are particularly suitable for placing a sling in a therapeutically effective position. The method may be utilized to support a variety of structures at different anatomical locations. Variations of these methods may occur due to individual surgeon's techniques or a patient's particular anatomy.


In accordance with one embodiment, a trans-obturator implant procedure is described. First, patient is positioned in a dorsal lithotomy position and prepared for surgery using standard operating procedures. Next, a surgeon makes a small vertical incision in the anterior vaginal wall beginning approximately 1 centimeter under the urethral meatus. The urethra is gently freed from the anterior vaginal wall. A scissor can then be used to dissect laterally in a 45 degree angle toward the ischiopubic ramus bone. The depth can then be checked digitally. These steps are repeated on the contralateral side.


The obturator fossa is then identified. This can be done by grasping the insertion of the adductor longus at its insertion to the pubic tubercle. By rocking a thumb under the adductor longus insertion, the superior portion of the obturator fossa can be identified. Next, two small skin incisions are made at the level of the clitoris in the fold of the thigh, facing the medial part of the obturator foramen.


The halo needle 114 is then inserted into of the skin incisions until the obturator membrane is perforated. The handle is orientated at approximately a 45 degree angle relative to the patients sagittal plane. Next, an index finger of the hand not holding the halo needle 114 can be placed in the ipsilateral dissection pouch. The halo needle 114 is guided behind the ischiopubic branch to meet the tip of the surgeon's index finger and guide the introducer tip 124 out of the vaginal incision. The surgeon's index finger can remain in contact with the tip 124 until the tip 124 is exteriorized. The connector 1000, which is already attached to a sheath assembly 800, can then be attached to the tip 124 of the halo needle 114. Detectable feedback of the connection can alert the surgeon the connector has been properly engaged. Traction can then be applied to the needle 114 or handle 612 to draw the sling tube 900 back through the skin incision. The above steps can then be repeated for the other side of the patient using the halo needle 214.


Next, a mesh sling is drawn into position within the sheath assembly, placing the tab 806, which is the mid-point of the mesh sling, under the mid-urethra. The two sides of the tab 806 are grasped and peeled away from the center of the sheath as indicated by the arrows on the tab 806. The tab 806 will then slide off of the two proximal ends of the sheath.


A blunt instrument is then placed between the urethra and the mesh while adjusting and positioning the sling. When the appropriate tension is attained, the sheath is removed to fully expose the mesh by pulling gently on both lateral ends of the sheath. The blunt instrument is kept in place under the urethra when removing the two ends of the sheath to ensure that over-tightening of the mesh does not occur. To complete the procedure, the exposed mesh strips are then cut at the level of the subcutaneous tissue and the skin incisions and vaginal incision are closed.


In accordance with one embodiment, a further trans-obturator implant procedure is described. First, patient is positioned in a dorsal lithotomy position and prepared for surgery using standard operating procedures. Next, a surgeon makes a small vertical incision in the anterior vaginal wall beginning approximately 1 centimeter under the urethral meatus. The urethra is gently freed from the anterior vaginal wall. A scissor can then be used to dissect laterally in a 45 degree angle toward the ischiopubic ramus bone. The depth can then be checked digitally. These steps are repeated on the contralateral side. The obturator fossa is then identified. This can be done by grasping the insertion of the adductor longus at its insertion to the pubic tubercle. By rocking a thumb under the adductor longus insertion, the superior portion of the obturator fossa can be identified. Next, two small skin incisions are made at the level of the clitoris in the fold of the thigh, facing the medial part of the obturator foramen.


The hook needle 310 is then inserted into of the skin incisions until the obturator membrane is perforated. The handle is then orientated at approximately a 45 degree angle relative to the patients sagittal plane. Next, an index finger of the hand not holding the hook needle 310 can be placed in the ipsilateral dissection pouch. The hook needle 310 is guided behind the ischiopubic branch to meet the tip of the surgeon's index finger and guide the introducer tip 324 out of the vaginal incision. The surgeon's index finger can remain in contact with the tip 324 until the tip 324 is exteriorized. The connector 1000, which is already attached to a sheath assembly 800, can then be attached to the tip 324 of the hook needle 310. Detectable feedback of the connection can alert the surgeon the connector has been properly engaged. Traction can then be applied to the hook needle 310 or handle 612 to draw the sling tube 900 back through the skin incision. The foregoing steps can then be repeated for the other side of the patient using a second hook needle similar to, or the same as, hook needle 310.


Next, a mesh sling is drawn into position within the sheath assembly, placing the tab 806, which is the mid-point of the mesh sling, under the mid-urethra. The two sides of the tab 806 are grasped and peeled away from the center of the sheath as indicated by the arrows on the tab 806. The tab 806 will then slide off of the two proximal ends of the sheath. A blunt instrument is then placed between the urethra and the mesh while adjusting and positioning the sling. When the appropriate tension is attained, the sheath is removed to fully expose the mesh by pulling gently on both lateral ends of the sheath. The blunt instrument is kept in place under the urethra when removing the two ends of the sheath to ensure that over-tightening of the mesh does not occur. To complete the procedure, the exposed mesh strips are then cut at the level of the subcutaneous tissue and the skin incisions and vaginal incision are closed.


In accordance with another embodiment, a suprapubic implant procedure is described. First, the lower abdominal and vaginal operative sites are prepared using normal surgical procedures. Next, two small abdominal incisions, approximately 1.5-2.0 cm in size, are made on each side of the midline just above the symphysis. Also, a small vertical incision is made in the anterior vaginal wall beginning approximately 1 cm under the urethral meatus. The urethra is gently freed from the anterior vaginal wall. Next, two small paraurethral dissections are made bilaterally to prepare for introducer insertion.


The needle 410 is inserted into one of the abdominal incisions. Using the posterior surface of the pubic bone, the needle 410 is then walked down toward the vaginal incision. Using the index finger of the other hand to meet the tip 424, the needle 410 is guided through the endopelvic fascia and into the vaginal incision. The connector 1000, which is already attached to a sheath assembly 800, is then attached to the tip 424 of the needle 410. Detectable feedback of the connection can alert the surgeon that the connector has been properly engaged. The needle 410 is then grasped and the sheath assembly is drawn up through the abdominal incision until the beginning of the tube 900 is visualized through the abdominal incision. The foregoing steps are repeated on the patient's contralateral side using a second needle introducer similar to, or the same as, needle 410. Once this is done, the tubes 900 should be in place and cystoscopy can be performed to confirm bladder integrity.


Next, a mesh sling is drawn into position within the sheath assembly, placing the tab 806, which is the mid-point of the mesh sling, under the mid-urethra. The two sides of the tab 806 are grasped and peeled away from the center of the sheath as indicated by the arrows on the tab 806. The tab 806 will then slide off of the two proximal ends of the sheath. A blunt instrument is then placed between the urethra and the mesh while adjusting and positioning the sling. When the appropriate tension is attained, the sheath is removed to fully expose the mesh by pulling gently on both lateral ends of the sheath. The blunt instrument is kept in place under the urethra when removing the two ends of the sheath to ensure that over-tightening of the mesh does not occur. To complete the procedure, the exposed mesh strips are then cut at the level of the subcutaneous tissue and the skin incisions and vaginal incision are closed.


In accordance with another embodiment, a retropubic implant procedure is described. First the lower abdominal and vaginal operative sites are prepared using normal surgical procedures. Next, two small abdominal incisions, approximately 1.5-2.0 cm in size, are made on each side of the midline just above the symphysis. Also, a small vertical incision is made in the anterior vaginal wall beginning approximately 1 cm under the urethral meatus. The urethra is gently freed from the anterior vaginal wall. Next, two small paraurethral dissections are made bilaterally to prepare for introducer insertion.


By first resting the tip 524 on the palmar surface of the non-dominant index finger, the needle 514 is inserted into one of the paraurethral spaces and the endopelvic fascia is perforated. The needle 514 is then guided through the space of Retzius and the rectus sheath and muscle are perforated. Next, the needle 514 is guided to the abdominal incision until the needle 514 is exposed through the incision. In a next step, the button 762 of the handle 712 is depressed and the needle 514 is disconnected from the handle 712 by sliding the handle 712 away from the patient. The connector 1000, which is already attached to a sheath assembly 800, is then attached to a distal end of the needle 515. Detectable feedback of the connection can alert the surgeon that the connector 100 has been properly engaged. The needle 514 is then grasped and the sheath assembly is drawn up through the abdominal incision until the beginning of the tube 900 is visualized through the abdominal incision. The foregoing steps are repeated on the patient's contralateral side using a second needle introducer similar to, or the same as, needle 514. Once this is done, the tubes 900 should be in place and cystoscopy can be performed to confirm bladder integrity.


Next, a mesh sling is drawn into position within the sheath assembly, placing the tab 806, which is the mid-point of the mesh sling, under the mid-urethra. The two sides of the tab 806 are grasped and peeled away from the center of the sheath as indicated by the arrows on the tab 806. The tab 806 will then slide off of the two proximal ends of the sheath. A blunt instrument is then placed between the urethra and the mesh while adjusting and positioning the sling. When the appropriate tension is attained, the sheath is removed to fully expose the mesh by pulling gently on both lateral ends of the sheath. The blunt instrument is kept in place under the urethra when removing the two ends of the sheath to ensure that over-tightening of the mesh does not occur. To complete the procedure, the exposed mesh strips are then cut at the level of the subcutaneous tissue and the skin incisions and vaginal incision are closed.


This invention has been described and specific examples of the invention have been portrayed. While the invention has been described in terms of particular variations and illustrative figures, those of ordinary skill in the art will recognize that the invention is not limited to the variations or figures described. In addition, where methods and steps described above indicate certain events occurring in certain order, those of ordinary skill in the art will recognize that the ordering of certain steps may be modified and that such modifications are in accordance with the variations of the invention. Additionally, certain of the steps may be performed concurrently in a parallel process when possible, as well as performed sequentially as described above. Therefore, to the extent there are variations of the invention, which are within the spirit of the disclosure or equivalent to the inventions found in the claims, it is the intent that this patent will cover those variations as well. Finally, all publications and patent applications cited in this specification are herein incorporated by reference in their entirety as if each individual publication or patent application were specifically and individually put forth herein.

Claims
  • 1. An introduction device for an implant, comprising: a handle, a first plane bisecting the handle between a top and a bottom thereof along a longitudinal axis; andan elongate member having a proximal end including a straight segment coupled to the handle and a distal end terminating in a tip, the elongate member including a first curved portion and a second curved portion, the entire second curved portion lying along a second plane perpendicular to the first plane, and the second curved portion touching the first plane at a first location along a path of the second curved portion from a proximal end of the second curved portion to a distal end of the second curved portion thereof and at a second location distal of the first location along the path.
  • 2. The introduction device according to claim 1, a space above the first plane including the top of the handle and a space below the first plane including the bottom of the handle, wherein the first curved portion lies substantially below the first plane.
  • 3. The introduction device according to claim 2, wherein a distal end of the first curved portion is connected to a proximal end of the second curved portion.
  • 4. The introduction device according to claim 1, wherein the first location is adjacent a proximal end of the second curved portion and the second location is adjacent a distal end of the second curved portion.
  • 5. The introduction device according to claim 1, a third plane bisecting the handle between opposing sides thereof, the third plane perpendicular to the first plane and the second plane, wherein the second curved portion passes through the third plane.
  • 6. The introduction device according to claim 5, wherein the second curved portion is asymmetrical with respect to the third plane.
  • 7. The introduction device according to claim 6, wherein the second curved portion includes a first arc from the proximal end of the second curved portion to the third plane and a second arc from the third plane to the distal end of the second curved portion.
  • 8. The introduction device according to claim 7, wherein the first arc has a radius of curvature greater than a radius of curvature of the second arc.
  • 9. The introduction device according to claim 5, wherein a first length measured along a straight line in the second plane from the proximal end of the second curved portion to the third plane is greater than a second length measured along a straight line in the second plane from the third plane to the distal end of the second curved portion.
  • 10. The introduction device according to claim 1, wherein a distal end of the first curved portion is connected to the proximal end of the second curved portion at a transition region.
  • 11. The introduction device according to claim 1, wherein the distal end of the second curved portion is substantially parallel to a third plane.
  • 12. The introduction device according to claim 11, wherein a proximal end of the first curved portion is connected to a distal end of the straight segment at a transition region.
  • 13. The introduction device according to claim 1, wherein the tip includes a first tip portion, a second tip portion connected to the first tip portion, and a third tip portion connected to the second tip portion, the first tip portion, the second tip portion and the third tip portion having different shapes.
  • 14. A kit for introducing an implant, comprising: a first introduction device, comprising a first handle having a length extending along a first longitudinal axis and being bisected by a first longitudinal plane extending along the first longitudinal axis, and a first elongate member having a proximal end coupled to a distal end of the first handle, the first elongate member including a first curved portion, the first curved portion lying entirely along a first perpendicular plane that is perpendicular to the first longitudinal axis, a first path along the first curved portion from a proximal end to a distal end thereof traveling in a first direction, the first curved portion touching the first longitudinal plane at a first location along the first path and at a second location distal of the first location along the first path; anda second introduction device, comprising a second handle having a length extending along a second longitudinal axis and being bisected by a second longitudinal plane extending along the second longitudinal axis, and a second elongate member having a proximal end coupled to a distal end of the second handle, the second elongate member including a second curved portion, the second curved portion lying entirely along a second perpendicular plane that is perpendicular to the second longitudinal axis, a second path along the second curved portion from a proximal end to a distal end traveling in a second direction opposite the first direction, the second curved portion touching the second longitudinal plane at a first location along the second path and at a second location distal of the first location along the second path.
  • 15. The kit according to claim 14, further comprising an implant including a sheath assembly and a mesh implant at least partially covered by the sheath assembly.
  • 16. An introducer needle comprising: a proximal section including a feature that enables engagement with a handle;a distal section; andan intermediate section disposed between the proximal section and the distal section, the introducer needle including, from a proximal end to a distal end thereof, a straight section along a longitudinal axis, a first curved section, and a second curved section lying entirely along a plane perpendicular to the longitudinal axis, the first curved section lying along a separate plane and having a radius of curvature along the separate plane greater than a radius of curvature of the second curved section along the plane perpendicular to the longitudinal axis.
  • 17. The introducer needle according to claim 16, wherein the distal section is substantially in a plane perpendicular to at least a portion of the proximal section.
  • 18. The introducer needle according to claim 16, wherein the proximal section is straight and is attached to the handle.
  • 19. The introducer needle according to claim 16, wherein the intermediate section is disposed at an angle relative to the proximal and distal sections.
PRIORITY

This application is a U.S. national stage application under 35 USC §371 of International Application No. PCT/US2007/078308, filed Sep. 12, 2007, which claims the benefit of priority to U.S. Provisional Patent Application No. No. 60/922,745, filed Apr. 9, 2007, and to U.S. Provisional Patent Application No. No. 60/825,417, filed Sep. 13, 2006, each of which is incorporated by reference into this application as if fully set forth herein.

PCT Information
Filing Document Filing Date Country Kind 371c Date
PCT/US2007/078308 9/12/2007 WO 00 5/24/2010
Publishing Document Publishing Date Country Kind
WO2008/033950 3/20/2008 WO A
US Referenced Citations (693)
Number Name Date Kind
107956 Peoble Oct 1870 A
1393107 Fuller Oct 1921 A
1450101 Mathewson Mar 1923 A
1758261 Leland May 1930 A
1924348 Brown Aug 1933 A
2042403 Hrivnak May 1936 A
2097018 Chamberlin Oct 1937 A
2137710 Anderson Nov 1938 A
2240330 Flagg et al. Apr 1941 A
2427176 Aldeen Sep 1947 A
2518994 Miller Aug 1950 A
2641249 Brockman Jun 1953 A
2666338 Sandberg Jan 1954 A
2738790 Todt et al. Mar 1956 A
3124136 Usher Mar 1964 A
3126600 De Marre Mar 1964 A
3182662 Shirodkar May 1965 A
3249104 Johnstein May 1966 A
3311110 Singerman et al. Mar 1967 A
3340494 Gutshall Sep 1967 A
3384073 Van Winkle, Jr. May 1968 A
3453729 Larson Jul 1969 A
3472232 Earl Oct 1969 A
3580313 McKnight May 1971 A
3714843 Bracey Feb 1973 A
3739430 Kohke Jun 1973 A
3763860 Clarke Oct 1973 A
3777737 Bucalo Dec 1973 A
3789828 Schulte Feb 1974 A
3858783 Kapitanov et al. Jan 1975 A
3913179 Rhee Oct 1975 A
3924633 Cook et al. Dec 1975 A
3976351 Hopfe Aug 1976 A
3995619 Glatzer Dec 1976 A
4019499 Fitzgerald Apr 1977 A
4037603 Wendorff Jul 1977 A
4063356 Hepworth et al. Dec 1977 A
4069956 Shearer, Sr. et al. Jan 1978 A
4089112 Richards May 1978 A
4128100 Wendorff Dec 1978 A
4172458 Pereyra Oct 1979 A
4204541 Kapitanov May 1980 A
4232445 Ito Nov 1980 A
4233734 Bies Nov 1980 A
4235238 Ogiu et al. Nov 1980 A
4246660 Wevers Jan 1981 A
4255881 Fralish Mar 1981 A
4258716 Sutherland et al. Mar 1981 A
4265231 Scheller, Jr. et al. May 1981 A
4281660 Fujiwara Aug 1981 A
4322885 Osada et al. Apr 1982 A
4361958 Gilbert et al. Dec 1982 A
4409866 McBride Oct 1983 A
4441497 Paudler Apr 1984 A
4452245 Usher Jun 1984 A
4455690 Homsy Jun 1984 A
4467802 Maslanka et al. Aug 1984 A
4509516 Richmond Apr 1985 A
4524771 McGregor et al. Jun 1985 A
4632100 Somers et al. Dec 1986 A
4655221 Devereux Apr 1987 A
4679453 Morita et al. Jul 1987 A
4712458 Mally Dec 1987 A
4718419 Okada et al. Jan 1988 A
4741335 Okada et al. May 1988 A
4773416 Hourahane Sep 1988 A
4775380 Seedhom et al. Oct 1988 A
4784139 Demos Nov 1988 A
4799484 Smith et al. Jan 1989 A
4857041 Annis et al. Aug 1989 A
4865031 O'Keeffe Sep 1989 A
4911164 Roth Mar 1990 A
4920986 Biswas May 1990 A
4938760 Burton et al. Jul 1990 A
4946467 Ohi et al. Aug 1990 A
5013292 Lemay et al. May 1991 A
5013316 Goble et al. May 1991 A
5026371 Rydell et al. Jun 1991 A
5027674 Nolte et al. Jul 1991 A
5029489 Burmeister et al. Jul 1991 A
5053043 Gottesman et al. Oct 1991 A
5084054 Bencini et al. Jan 1992 A
5085661 Moss Feb 1992 A
5112344 Petros May 1992 A
5122155 Eberbach Jun 1992 A
5123428 Schwarz Jun 1992 A
5123910 McIntosh Jun 1992 A
5149329 Richardson Sep 1992 A
5152749 Giesy et al. Oct 1992 A
5152778 Bales, Jr. et al. Oct 1992 A
5163942 Rydell Nov 1992 A
5171233 Amplatz et al. Dec 1992 A
5171314 Dulebohn Dec 1992 A
5188636 Fedotov Feb 1993 A
5201741 Dulebohn Apr 1993 A
5207694 Broome May 1993 A
5209756 Seedhom et al. May 1993 A
5234436 Eaton et al. Aug 1993 A
5246452 Sinnott Sep 1993 A
5250033 Evans et al. Oct 1993 A
5256133 Spitz Oct 1993 A
5269063 Okada et al. Dec 1993 A
5281237 Gimpelson Jan 1994 A
5304187 Green et al. Apr 1994 A
5311858 Adair May 1994 A
5328077 Lou Jul 1994 A
5333624 Tovey Aug 1994 A
5334185 Giesy et al. Aug 1994 A
5336239 Gimpelson Aug 1994 A
5337736 Reddy Aug 1994 A
5342371 Welter et al. Aug 1994 A
5356432 Rutkow et al. Oct 1994 A
5362294 Seitzinger Nov 1994 A
5368595 Lewis Nov 1994 A
5368602 de la Torre Nov 1994 A
5380334 Torrie et al. Jan 1995 A
5383904 Totakura et al. Jan 1995 A
5386836 Biswas Feb 1995 A
5397332 Kammerer et al. Mar 1995 A
5397353 Oliver et al. Mar 1995 A
5403328 Shallman Apr 1995 A
5413598 Moreland May 1995 A
5439467 Benderev et al. Aug 1995 A
5447512 Wilson et al. Sep 1995 A
5456721 Legrand Oct 1995 A
5473796 Fusillo Dec 1995 A
5474543 McKay Dec 1995 A
5486183 Middleman et al. Jan 1996 A
5497553 Chong et al. Mar 1996 A
5499991 Garman et al. Mar 1996 A
5500000 Feagin et al. Mar 1996 A
5501692 Riza Mar 1996 A
5502896 Chen et al. Apr 1996 A
5509900 Kirkman Apr 1996 A
5520700 Beyar et al. May 1996 A
5520703 Essig et al. May 1996 A
5522833 Stephens et al. Jun 1996 A
5542948 Weaver et al. Aug 1996 A
5544664 Benderev et al. Aug 1996 A
5549619 Peters et al. Aug 1996 A
5549676 Johnson Aug 1996 A
5562678 Booker Oct 1996 A
5562685 Mollenauer et al. Oct 1996 A
5562688 Riza Oct 1996 A
5562689 Green et al. Oct 1996 A
5569269 Hart et al. Oct 1996 A
5571139 Jenkins, Jr. Nov 1996 A
5573530 Fleury et al. Nov 1996 A
5591163 Thompson Jan 1997 A
5601558 Torrie et al. Feb 1997 A
5611515 Benderev et al. Mar 1997 A
5628756 Barker, Jr. et al. May 1997 A
5633286 Chen May 1997 A
5640886 Lai et al. Jun 1997 A
5643320 Lower et al. Jul 1997 A
5647836 Blake, III et al. Jul 1997 A
5655270 Boisvert Aug 1997 A
5662683 Kay Sep 1997 A
5667513 Torrie et al. Sep 1997 A
5669935 Rosenman et al. Sep 1997 A
5683349 Makower et al. Nov 1997 A
5689860 Matoba et al. Nov 1997 A
5693072 McIntosh Dec 1997 A
5702397 Goble et al. Dec 1997 A
5755728 Maki May 1998 A
5774994 Stein et al. Jul 1998 A
5792142 Galitzer Aug 1998 A
5807403 Beyar et al. Sep 1998 A
5810882 Bolduc et al. Sep 1998 A
5817104 Bilitz et al. Oct 1998 A
5817128 Storz et al. Oct 1998 A
5830220 Wan et al. Nov 1998 A
5836053 Davignon et al. Nov 1998 A
5836314 Benderev et al. Nov 1998 A
5836315 Benderev et al. Nov 1998 A
5840011 Landgrebe et al. Nov 1998 A
5842478 Benderev et al. Dec 1998 A
5846248 Chu et al. Dec 1998 A
5860425 Benderev et al. Jan 1999 A
5862596 Chung et al. Jan 1999 A
5864952 Chung et al. Feb 1999 A
5899909 Claren et al. May 1999 A
5904692 Steckel et al. May 1999 A
5904696 Rosenman May 1999 A
5910148 Reimels et al. Jun 1999 A
5919232 Chaffringeon et al. Jul 1999 A
5934283 Willem et al. Aug 1999 A
5935122 Fourkas et al. Aug 1999 A
5935138 McJames, II et al. Aug 1999 A
5944732 Raulerson et al. Aug 1999 A
5947978 Holsinger Sep 1999 A
5961526 Chu et al. Oct 1999 A
5968008 Grams Oct 1999 A
5971967 Willard Oct 1999 A
5972000 Beyar et al. Oct 1999 A
5987751 Chung et al. Nov 1999 A
5988171 Sohn et al. Nov 1999 A
5992269 Puig et al. Nov 1999 A
5993459 Larsen et al. Nov 1999 A
5997554 Thompson Dec 1999 A
6005191 Tzeng et al. Dec 1999 A
6006433 Baltazar Dec 1999 A
6010447 Kardjian Jan 2000 A
6030393 Corlew Feb 2000 A
6031148 Hayes et al. Feb 2000 A
6039686 Kovac Mar 2000 A
6042534 Gellman et al. Mar 2000 A
6042536 Tihon et al. Mar 2000 A
6048351 Gordon et al. Apr 2000 A
6048354 Lawrence Apr 2000 A
6050937 Benderev Apr 2000 A
6053925 Barnhart Apr 2000 A
6053935 Brenneman et al. Apr 2000 A
6056688 Benderev et al. May 2000 A
6059796 Bilitz et al. May 2000 A
6063094 Rosenberg et al. May 2000 A
6068591 Bruckner et al. May 2000 A
6068648 Cole et al. May 2000 A
6071290 Compton Jun 2000 A
6074341 Anderson et al. Jun 2000 A
6086591 Bojarski Jul 2000 A
6092955 Chartrain et al. Jul 2000 A
6096041 Gellman et al. Aug 2000 A
6096060 Fitts et al. Aug 2000 A
6099538 Moses et al. Aug 2000 A
6106545 Egan Aug 2000 A
6110101 Tihon et al. Aug 2000 A
6117067 Gil-Vernet Sep 2000 A
6117162 Schmieding et al. Sep 2000 A
6168611 Rizvi Jan 2001 B1
6171315 Chu et al. Jan 2001 B1
6197036 Tripp et al. Mar 2001 B1
6200330 Benderev et al. Mar 2001 B1
6210416 Chu et al. Apr 2001 B1
6221005 Bruckner et al. Apr 2001 B1
6221060 Willard Apr 2001 B1
6226873 Okumura et al. May 2001 B1
6235026 Smith May 2001 B1
6273852 Lehe et al. Aug 2001 B1
6290702 Fucci et al. Sep 2001 B1
6293961 Schwartz et al. Sep 2001 B2
6302840 Benderev Oct 2001 B1
6306079 Trabucco Oct 2001 B1
6306159 Schwartz et al. Oct 2001 B1
6312448 Bonutti Nov 2001 B1
6315782 Chu et al. Nov 2001 B1
6319271 Schwartz et al. Nov 2001 B1
6322492 Kovac Nov 2001 B1
6328686 Kovac Dec 2001 B1
6328744 Harari et al. Dec 2001 B1
6328758 Tornier et al. Dec 2001 B1
6334446 Beyar Jan 2002 B1
6336731 Chien Jan 2002 B1
6346109 Fucci et al. Feb 2002 B1
6346115 Lawrence Feb 2002 B1
6352553 van der Burg et al. Mar 2002 B1
6355065 Gabbay Mar 2002 B1
6358197 Silverman et al. Mar 2002 B1
6367353 Brucart Puig et al. Apr 2002 B2
6371963 Nishtala et al. Apr 2002 B1
6375661 Chu et al. Apr 2002 B2
6382214 Raz et al. May 2002 B1
D458679 Thompson et al. Jun 2002 S
6406423 Scetbon Jun 2002 B1
6406480 Beyar et al. Jun 2002 B1
6409733 Conlon et al. Jun 2002 B1
6423080 Gellman et al. Jul 2002 B1
6432123 Schwartz et al. Aug 2002 B2
6440154 Gellman et al. Aug 2002 B2
6475139 Miller Nov 2002 B1
6478727 Scetbon et al. Nov 2002 B2
6478803 Kapec et al. Nov 2002 B1
6482214 Sidor, Jr. et al. Nov 2002 B1
6491703 Ulmsten et al. Dec 2002 B1
6491714 Bennett Dec 2002 B1
6494887 Kaladelfos et al. Dec 2002 B1
6494906 Owens Dec 2002 B1
6502578 Raz et al. Jan 2003 B2
6506190 Walshe Jan 2003 B1
6511499 Schmieding et al. Jan 2003 B2
6517552 Nord et al. Feb 2003 B1
6530943 Hoepffner et al. Mar 2003 B1
6537198 Vidlund et al. Mar 2003 B1
6544267 Cole et al. Apr 2003 B1
6553674 Budrow Apr 2003 B1
6554842 Heuser et al. Apr 2003 B2
6569188 Grafton et al. May 2003 B2
6575976 Grafton Jun 2003 B2
6575984 Beyar et al. Jun 2003 B2
6575998 Beyar et al. Jun 2003 B2
6582443 Cabak et al. Jun 2003 B2
6591838 Durgin Jul 2003 B2
6592515 Thierfelder et al. Jul 2003 B2
6592610 Beyar Jul 2003 B2
6596001 Stormby et al. Jul 2003 B2
6605097 Lehe et al. Aug 2003 B1
6612977 Staskin et al. Sep 2003 B2
6626917 Craig Sep 2003 B1
6638209 Landgrebe et al. Oct 2003 B2
6638210 Berger Oct 2003 B2
6638211 Suslian et al. Oct 2003 B2
6638286 Burbank et al. Oct 2003 B1
6641524 Kovac Nov 2003 B2
6641525 Rocheleau et al. Nov 2003 B2
6652450 Neisz et al. Nov 2003 B2
6652537 Mercereau et al. Nov 2003 B2
6656183 Colleran et al. Dec 2003 B2
6663633 Pierson, III Dec 2003 B1
6663645 Nishtala et al. Dec 2003 B2
6673010 Skiba et al. Jan 2004 B2
6675483 Bond et al. Jan 2004 B2
6676668 Mercereau et al. Jan 2004 B2
6685629 Therin Feb 2004 B2
6689047 Gellman Feb 2004 B2
6691711 Raz et al. Feb 2004 B2
6702827 Lund et al. Mar 2004 B1
6708410 Okada et al. Mar 2004 B2
6712830 Esplin Mar 2004 B2
6730097 Dennis May 2004 B2
6730110 Harari et al. May 2004 B1
6736854 Vadurro et al. May 2004 B2
6737371 Planck et al. May 2004 B1
6746472 Frazier et al. Jun 2004 B2
6752814 Gellman et al. Jun 2004 B2
6755781 Gellman Jun 2004 B2
6761722 Cole et al. Jul 2004 B2
6789326 Huang et al. Sep 2004 B1
6802807 Anderson et al. Oct 2004 B2
6808486 O'Donnell Oct 2004 B1
6808487 Migliari et al. Oct 2004 B2
6835193 Epstein et al. Dec 2004 B2
6843792 Nishtala et al. Jan 2005 B2
6872227 Sump et al. Mar 2005 B2
6878134 Rogers et al. Apr 2005 B2
6881184 Zappala Apr 2005 B2
6908425 Luscombe Jun 2005 B2
6911003 Anderson et al. Jun 2005 B2
6932759 Kammerer et al. Aug 2005 B2
6936052 Gellman et al. Aug 2005 B2
6953428 Gellman et al. Oct 2005 B2
6960160 Browning et al. Nov 2005 B2
6966113 Fossella Nov 2005 B2
6971390 Vasek et al. Dec 2005 B1
6971986 Staskin et al. Dec 2005 B2
6986781 Smith Jan 2006 B2
6987995 Drysen Jan 2006 B2
6991597 Gellman et al. Jan 2006 B2
7014607 Gellman Mar 2006 B2
7025063 Snitkin et al. Apr 2006 B2
7025756 Frazier et al. Apr 2006 B2
7025772 Gellman et al. Apr 2006 B2
7033380 Schwartz et al. Apr 2006 B2
7037255 Inman et al. May 2006 B2
7037307 Dennis May 2006 B2
7037324 Martinek May 2006 B2
7044905 Vidlund et al. May 2006 B2
7048682 Neisz et al. May 2006 B2
7052495 Smith May 2006 B2
7056333 Walshe Jun 2006 B2
7063716 Cunningham Jun 2006 B2
7070556 Anderson et al. Jul 2006 B2
7070558 Gellman et al. Jul 2006 B2
7083568 Neisz et al. Aug 2006 B2
7083648 Yu et al. Aug 2006 B2
7087065 Ulmsten et al. Aug 2006 B2
7094199 Petros et al. Aug 2006 B2
7101378 Salameh et al. Sep 2006 B2
7112171 Rocheleau et al. Sep 2006 B2
7112210 Ulmsten et al. Sep 2006 B2
7121997 Kammerer et al. Oct 2006 B2
7131943 Kammerer Nov 2006 B2
7131944 Jacquetin et al. Nov 2006 B2
7163506 Grise Jan 2007 B2
7198597 Siegel et al. Apr 2007 B2
7204801 Grocela Apr 2007 B2
7204802 De Leval et al. Apr 2007 B2
RE39626 Tihon May 2007 E
D543626 Watschke et al. May 2007 S
7217264 Gobron et al. May 2007 B2
7226407 Kammerer et al. Jun 2007 B2
7226408 Harai et al. Jun 2007 B2
7229453 Anderson et al. Jun 2007 B2
7235043 Gellman et al. Jun 2007 B2
7244259 Smith et al. Jul 2007 B2
7261723 Smith et al. Aug 2007 B2
7267645 Anderson et al. Sep 2007 B2
7285086 Smith et al. Oct 2007 B2
7288063 Petros et al. Oct 2007 B2
7291104 Neisz et al. Nov 2007 B2
7297102 Smith et al. Nov 2007 B2
7303525 Watschke et al. Dec 2007 B2
7326213 Benderev et al. Feb 2008 B2
7338432 Valtchev Mar 2008 B2
7347812 Mellier et al. Mar 2008 B2
7347813 Claren et al. Mar 2008 B2
7351196 Goldmann et al. Apr 2008 B2
7351197 Montpetit et al. Apr 2008 B2
7357773 Watschke Apr 2008 B2
7364541 Chu et al. Apr 2008 B2
7371245 Evans et al. May 2008 B2
7387634 Benderev Jun 2008 B2
7402133 Chu et al. Jul 2008 B2
7404819 Darios et al. Jul 2008 B1
7407480 Staskin et al. Aug 2008 B2
7410460 Benderev Aug 2008 B2
7413540 Gellman et al. Aug 2008 B2
7422557 Arnal et al. Sep 2008 B2
7500945 Cox et al. Mar 2009 B2
7527588 Zaddem et al. May 2009 B2
7588598 Delorme et al. Sep 2009 B2
7611454 De Leval Nov 2009 B2
7621864 Suslian et al. Nov 2009 B2
7621865 Gellman et al. Nov 2009 B2
7628156 Astani et al. Dec 2009 B2
7658743 Ulmsten Feb 2010 B2
7691050 Gellman et al. Apr 2010 B2
7691052 Gellman et al. Apr 2010 B2
7691110 Secrest et al. Apr 2010 B2
7722527 Bouchier et al. May 2010 B2
7771345 O'Donnell Aug 2010 B1
7789821 Browning Sep 2010 B2
7867161 Staskin et al. Jan 2011 B2
7878969 Chu et al. Feb 2011 B2
7896848 Charukhchian Mar 2011 B2
7981023 Nowlin et al. Jul 2011 B2
7988615 Anderson et al. Aug 2011 B2
8007430 Browning Aug 2011 B2
8033983 Chu et al. Oct 2011 B2
8057383 Weiser et al. Nov 2011 B2
8092366 Evans Jan 2012 B2
8097007 Evans et al. Jan 2012 B2
8123671 Evans Feb 2012 B2
8206280 Evans et al. Jun 2012 B2
20010000533 Kovac Apr 2001 A1
20010008549 Hashimoto Jul 2001 A1
20010010008 Gellman et al. Jul 2001 A1
20010049467 Lehe et al. Dec 2001 A1
20010051807 Grafton Dec 2001 A1
20010053916 Rioux Dec 2001 A1
20020007222 Desai Jan 2002 A1
20020022841 Kovac Feb 2002 A1
20020028980 Thierfelder et al. Mar 2002 A1
20020052653 Durgin May 2002 A1
20020055748 Gellman et al. May 2002 A1
20020058959 Gellman May 2002 A1
20020068948 Stormby et al. Jun 2002 A1
20020072694 Snitkin et al. Jun 2002 A1
20020077526 Kammerer et al. Jun 2002 A1
20020078964 Kovac et al. Jun 2002 A1
20020082619 Cabak et al. Jun 2002 A1
20020091373 Berger Jul 2002 A1
20020091391 Cole et al. Jul 2002 A1
20020095181 Beyar Jul 2002 A1
20020099258 Staskin et al. Jul 2002 A1
20020099259 Anderson et al. Jul 2002 A1
20020099260 Suslian et al. Jul 2002 A1
20020107430 Neisz et al. Aug 2002 A1
20020107525 Harari et al. Aug 2002 A1
20020115906 Miller Aug 2002 A1
20020128670 Ulmsten et al. Sep 2002 A1
20020138025 Gellman et al. Sep 2002 A1
20020147382 Neisz et al. Oct 2002 A1
20020151762 Rocheleau et al. Oct 2002 A1
20020151909 Gellman et al. Oct 2002 A1
20020151910 Gellman et al. Oct 2002 A1
20020156487 Gellman et al. Oct 2002 A1
20020156488 Gellman et al. Oct 2002 A1
20020156489 Gellman et al. Oct 2002 A1
20020165566 Ulmsten Nov 2002 A1
20020188169 Kammerer et al. Dec 2002 A1
20020188301 Dallara et al. Dec 2002 A1
20030004395 Therin Jan 2003 A1
20030009181 Gellman et al. Jan 2003 A1
20030023136 Raz et al. Jan 2003 A1
20030023137 Gellman Jan 2003 A1
20030023138 Luscombe Jan 2003 A1
20030036676 Scetbon Feb 2003 A1
20030036770 Markman Feb 2003 A1
20030045774 Staskin et al. Mar 2003 A1
20030045892 Kaladelfos Mar 2003 A1
20030050530 Neisz et al. Mar 2003 A1
20030065246 Inman et al. Apr 2003 A1
20030065402 Anderson et al. Apr 2003 A1
20030078604 Walshe Apr 2003 A1
20030088250 Colleran et al. May 2003 A1
20030130670 Anderson et al. Jul 2003 A1
20030135239 Gabriel et al. Jul 2003 A1
20030149440 Kammerer et al. Aug 2003 A1
20030171644 Anderson et al. Sep 2003 A1
20030176762 Kammerer Sep 2003 A1
20030176875 Anderson et al. Sep 2003 A1
20030191360 Browning Oct 2003 A1
20030199732 Suslian et al. Oct 2003 A1
20030212305 Anderson et al. Nov 2003 A1
20030216693 Mickley Nov 2003 A1
20030220538 Jacquetin Nov 2003 A1
20030225424 Benderev Dec 2003 A1
20030229350 Kay Dec 2003 A1
20040006353 Bosley et al. Jan 2004 A1
20040015048 Neisz et al. Jan 2004 A1
20040015057 Rocheleau et al. Jan 2004 A1
20040039246 Gellman et al. Feb 2004 A1
20040039453 Anderson et al. Feb 2004 A1
20040040159 Fossella Mar 2004 A1
20040044364 DeVries et al. Mar 2004 A1
20040059336 Lombardo et al. Mar 2004 A1
20040068159 Neisz et al. Apr 2004 A1
20040073219 Skiba et al. Apr 2004 A1
20040073234 Chu et al. Apr 2004 A1
20040087970 Chu et al. May 2004 A1
20040087980 Ford et al. May 2004 A1
20040097974 De Leval May 2004 A1
20040097975 Rose May 2004 A1
20040106845 Anderson et al. Jun 2004 A1
20040106847 Benderev Jun 2004 A1
20040106925 Culbert Jun 2004 A1
20040111895 Huang Jun 2004 A1
20040116774 Migliari Jun 2004 A1
20040116944 Chu et al. Jun 2004 A1
20040122474 Gellman et al. Jun 2004 A1
20040406847 Benderev Jun 2004
20040133217 Watschke Jul 2004 A1
20040144395 Evans et al. Jul 2004 A1
20040153008 Sharf et al. Aug 2004 A1
20040153074 Bojarski et al. Aug 2004 A1
20040153103 Schwartz et al. Aug 2004 A1
20040172048 Browning Sep 2004 A1
20040209538 Klinge et al. Oct 2004 A1
20040220595 Frazier et al. Nov 2004 A1
20040225181 Chu et al. Nov 2004 A1
20040225301 Roop et al. Nov 2004 A1
20040230206 Gellman et al. Nov 2004 A1
20040230207 Gellman et al. Nov 2004 A1
20040231678 Fierro Nov 2004 A1
20040249240 Goldmann et al. Dec 2004 A1
20040249396 Lund et al. Dec 2004 A1
20040249473 Delorme et al. Dec 2004 A1
20040254609 Esplin Dec 2004 A1
20040267088 Kammerer Dec 2004 A1
20050004576 Benderev Jan 2005 A1
20050021086 De Leval Jan 2005 A1
20050028380 Fossella Feb 2005 A1
20050033365 Courage Feb 2005 A1
20050038370 Kuth et al. Feb 2005 A1
20050043580 Watschke et al. Feb 2005 A1
20050065395 Mellier Mar 2005 A1
20050070829 Therin et al. Mar 2005 A1
20050075654 Kelleher Apr 2005 A1
20050075660 Chu et al. Apr 2005 A1
20050085831 Rioux Apr 2005 A1
20050090706 Gellman et al. Apr 2005 A1
20050090841 Morrison Apr 2005 A1
20050101834 Merade May 2005 A1
20050101973 Smith et al. May 2005 A1
20050107660 Valtchev May 2005 A1
20050113845 Griego et al. May 2005 A1
20050131274 Suslian et al. Jun 2005 A1
20050131391 Chu Jun 2005 A1
20050131392 Chu et al. Jun 2005 A1
20050131393 Chu et al. Jun 2005 A1
20050131429 Ho et al. Jun 2005 A1
20050143618 Anderson et al. Jun 2005 A1
20050148813 Claren et al. Jul 2005 A1
20050149122 McDevitt et al. Jul 2005 A1
20050177022 Chu et al. Aug 2005 A1
20050228413 Binmoeller et al. Oct 2005 A1
20050234291 Gingras Oct 2005 A1
20050240076 Neisz et al. Oct 2005 A1
20050251083 Carr-Brendel et al. Nov 2005 A1
20050251159 Ewers et al. Nov 2005 A1
20050251177 Saadat et al. Nov 2005 A1
20050251202 Ewers et al. Nov 2005 A1
20050251210 Westra et al. Nov 2005 A1
20050256366 Chu Nov 2005 A1
20050256530 Petros Nov 2005 A1
20050261545 Gellman et al. Nov 2005 A1
20050273138 To et al. Dec 2005 A1
20050277806 Cristalli Dec 2005 A1
20050277807 MacLean et al. Dec 2005 A1
20050277966 Ewers et al. Dec 2005 A1
20050277981 Maahs et al. Dec 2005 A1
20050283040 Greenhalgh Dec 2005 A1
20050288689 Kammerer et al. Dec 2005 A1
20060015001 Staskin et al. Jan 2006 A1
20060015069 Evans et al. Jan 2006 A1
20060025649 Smith et al. Feb 2006 A1
20060041185 Browning Feb 2006 A1
20060058574 Priewe et al. Mar 2006 A1
20060058575 Zaddem et al. Mar 2006 A1
20060058578 Browning Mar 2006 A1
20060059693 Fossella Mar 2006 A1
20060059695 Levine et al. Mar 2006 A1
20060063968 Anderson et al. Mar 2006 A1
20060089524 Chu Apr 2006 A1
20060089525 Mamo et al. Apr 2006 A1
20060100628 Martinek May 2006 A1
20060106277 Romero Maroto May 2006 A1
20060116719 Martinek Jun 2006 A1
20060122457 Kovac et al. Jun 2006 A1
20060130848 Carey Jun 2006 A1
20060134159 Nicita Jun 2006 A1
20060149123 Vidlund et al. Jul 2006 A1
20060173237 Jacquetin Aug 2006 A1
20060173468 Simmon et al. Aug 2006 A1
20060173471 Carr, Jr. et al. Aug 2006 A1
20060173864 Dart et al. Aug 2006 A1
20060183966 Neisz et al. Aug 2006 A1
20060184234 Frazier et al. Aug 2006 A1
20060195007 Anderson et al. Aug 2006 A1
20060195010 Arnal et al. Aug 2006 A1
20060195011 Arnal et al. Aug 2006 A1
20060195013 Gellman et al. Aug 2006 A1
20060196137 Brenzel et al. Sep 2006 A1
20060199994 Inman et al. Sep 2006 A1
20060199996 Caraballo et al. Sep 2006 A1
20060201519 Frazier et al. Sep 2006 A1
20060205995 Browning Sep 2006 A1
20060205998 Li et al. Sep 2006 A1
20060207606 Roue et al. Sep 2006 A1
20060217762 Maahs et al. Sep 2006 A1
20060229493 Weiser et al. Oct 2006 A1
20060229596 Weiser et al. Oct 2006 A1
20060235262 Arnal et al. Oct 2006 A1
20060235447 Walshe Oct 2006 A1
20060247490 Merade et al. Nov 2006 A1
20060252980 Arnal et al. Nov 2006 A1
20060258897 Petros et al. Nov 2006 A1
20060258898 Montpetit et al. Nov 2006 A1
20060260618 Hodroff et al. Nov 2006 A1
20060264698 Kondonis et al. Nov 2006 A1
20060287571 Gozzi et al. Dec 2006 A1
20070010830 Gellman et al. Jan 2007 A1
20070015957 Li Jan 2007 A1
20070021649 Nowlin et al. Jan 2007 A1
20070021650 Rocheleau et al. Jan 2007 A1
20070021686 Gellman et al. Jan 2007 A1
20070032695 Weiser Feb 2007 A1
20070038017 Chu Feb 2007 A1
20070038018 Chu Feb 2007 A1
20070043255 O'Donnell Feb 2007 A1
20070043336 Griffin et al. Feb 2007 A1
20070049790 Wagner et al. Mar 2007 A1
20070049791 Merade et al. Mar 2007 A1
20070055094 Chen Mar 2007 A1
20070055095 Chu et al. Mar 2007 A1
20070060788 Gellman Mar 2007 A1
20070062541 Zhou et al. Mar 2007 A1
20070068538 Anderson et al. Mar 2007 A1
20070078295 Landgrebe Apr 2007 A1
20070088390 Paz et al. Apr 2007 A1
20070089750 Astani et al. Apr 2007 A1
20070089751 Astani et al. Apr 2007 A1
20070123746 MacLean May 2007 A1
20070142698 Bourne et al. Jun 2007 A1
20070156012 Tracey et al. Jul 2007 A1
20070161849 Goldberg Jul 2007 A1
20070203429 Ziv Aug 2007 A1
20070225546 Anderson et al. Sep 2007 A1
20070299299 Rosenblatt Dec 2007 A1
20070299300 Smith et al. Dec 2007 A1
20080004490 Bosley et al. Jan 2008 A1
20080009665 Merade et al. Jan 2008 A1
20080009667 Longhini et al. Jan 2008 A1
20080009888 Ewers et al. Jan 2008 A1
20080039678 Montpetit et al. Feb 2008 A1
20080045782 Jimenez Feb 2008 A1
20080082121 Chu Apr 2008 A1
20080097329 Hodroff et al. Apr 2008 A1
20080132753 Goddard Jun 2008 A1
20080269547 Hortenstine Oct 2008 A1
20080281148 Evans et al. Nov 2008 A1
20080300607 Meade et al. Dec 2008 A1
20090105743 Chu Apr 2009 A1
20090137862 Evans et al. May 2009 A1
20090149700 Garcia et al. Jun 2009 A1
20090221868 Evans Sep 2009 A1
20090306464 Griguol Dec 2009 A1
20090318752 Evans et al. Dec 2009 A1
20100010501 Meade et al. Jan 2010 A2
20100030015 Delorme et al. Feb 2010 A1
20100056856 Suslian et al. Mar 2010 A1
20100197999 Deegan et al. Aug 2010 A1
20100217069 Meade et al. Aug 2010 A1
20100234679 Evans Sep 2010 A1
20100241105 Meade et al. Sep 2010 A1
20110082328 Gozzi et al. Apr 2011 A1
20110105833 Gozzi et al. May 2011 A1
20110124954 Ogdahl et al. May 2011 A1
20110282133 Anderson et al. Nov 2011 A1
20120029488 Chu Feb 2012 A1
20120108890 Evans May 2012 A1
20120116154 Evans et al. May 2012 A1
20120253110 Evans et al. Oct 2012 A1
Foreign Referenced Citations (185)
Number Date Country
2592617 Jan 2012 CA
3223153 Aug 1983 DE
4220283 Dec 1993 DE
4334419 Apr 1995 DE
19544162 Apr 1997 DE
10138950 Feb 2003 DE
102 11 360 Oct 2003 DE
10245076 Apr 2004 DE
0437481 Jul 1991 EP
0537769 Apr 1993 EP
0556313 Aug 1993 EP
0557964 Sep 1993 EP
0598976 Jun 1994 EP
0619984 Oct 1994 EP
0648474 Apr 1995 EP
0668056 Aug 1995 EP
0692225 Jan 1996 EP
0740925 Nov 1996 EP
0745351 Dec 1996 EP
0774240 May 1997 EP
0778749 Jun 1997 EP
0854691 Jul 1998 EP
0913162 May 1999 EP
0941712 Sep 1999 EP
0983033 Mar 2000 EP
1018980 Jul 2000 EP
1093758 Apr 2001 EP
1151722 Nov 2001 EP
1159920 Dec 2001 EP
1159921 Dec 2001 EP
1239793 Sep 2002 EP
1239795 81 Sep 2002 EP
1342450 Sep 2003 EP
1342454 Sep 2003 EP
1399082 Mar 2004 EP
1417934 May 2004 EP
1487377 Dec 2004 EP
1534154 Jun 2005 EP
1549245 Jul 2005 EP
1600118 Nov 2005 EP
1609439 Dec 2005 EP
1610714 Jan 2006 EP
1688105 Aug 2006 EP
1909672 Apr 2008 EP
1545285 Nov 2010 EP
1948073 Mar 2011 EP
2712177 May 1995 FR
2785521 May 2000 FR
0102120 Jan 2002 FR
2852817 Oct 2004 FR
2859624 Mar 2005 FR
2859901 Mar 2005 FR
2382993 Jun 2003 GB
03070567 Mar 1991 JP
05161655 Jun 1993 JP
11221221 Aug 1999 JP
2002503510 Feb 2002 JP
2002143290 May 2002 JP
2003501144 Jan 2003 JP
2003225240 Aug 2003 JP
2005505313 Feb 2005 JP
2005534422 Nov 2005 JP
4452180 Apr 2010 JP
503271 Apr 1996 SE
9003766 Apr 1990 WO
9003766 Apr 1990 WO
9208412 May 1992 WO
9310731 Jun 1993 WO
9315690 Aug 1993 WO
9603091 Feb 1996 WO
9606567 Mar 1996 WO
9606567 Mar 1996 WO
9606597 Mar 1996 WO
9607355 Mar 1996 WO
9608587 Mar 1996 WO
9640307 Dec 1996 WO
9713465 Apr 1997 WO
9713465 Apr 1997 WO
9716121 May 1997 WO
9743982 Nov 1997 WO
9831301 Jul 1998 WO
9835632 Aug 1998 WO
9835632 Aug 1998 WO
9922873 May 1999 WO
9934744 Jul 1999 WO
9942041 Aug 1999 WO
9959477 Nov 1999 WO
0018325 Apr 2000 WO
0027304 May 2000 WO
0027304 May 2000 WO
0040158 Jul 2000 WO
0064370 Nov 2000 WO
0066030 Nov 2000 WO
0074594 Dec 2000 WO
0074594 Dec 2000 WO
0074613 Dec 2000 WO
0074613 Dec 2000 WO
0074633 Dec 2000 WO
0106951 Feb 2001 WO
0130246 May 2001 WO
0147438 Jul 2001 WO
0152750 Jul 2001 WO
0180774 Nov 2001 WO
0193656 Dec 2001 WO
0202031 Jan 2002 WO
0202031 Jan 2002 WO
0219945 Mar 2002 WO
0219946 Mar 2002 WO
0226108 Apr 2002 WO
0228312 Apr 2002 WO
0228312 Apr 2002 WO
0228315 Apr 2002 WO
0232284 Apr 2002 WO
0238079 May 2002 WO
0239890 May 2002 WO
0239914 May 2002 WO
02058562 Aug 2002 WO
02058562 Aug 2002 WO
02058563 Aug 2002 WO
02058564 Aug 2002 WO
02058565 Aug 2002 WO
02058565 Aug 2002 WO
02062237 Aug 2002 WO
02065921 Aug 2002 WO
02065922 Aug 2002 WO
02065923 Aug 2002 WO
02065923 Aug 2002 WO
02069781 Sep 2002 WO
02071931 Sep 2002 WO
02071931 Sep 2002 WO
02078548 Oct 2002 WO
02098322 Dec 2002 WO
02098322 Dec 2002 WO
03002027 Jan 2003 WO
03002027 Jan 2003 WO
03013369 Feb 2003 WO
03028585 Apr 2003 WO
03037215 May 2003 WO
03053252 Jul 2003 WO
03068107 Aug 2003 WO
03068107 Aug 2003 WO
03073960 Sep 2003 WO
03075792 Sep 2003 WO
03086205 Oct 2003 WO
03092546 Nov 2003 WO
03096928 Nov 2003 WO
03096929 Nov 2003 WO
03096930 Nov 2003 WO
03096930 Nov 2003 WO
03101344 Dec 2003 WO
2004004600 Jan 2004 WO
2004008977 Jan 2004 WO
2004012579 Feb 2004 WO
2004012626 Feb 2004 WO
2004016196 Feb 2004 WO
2004017862 Mar 2004 WO
2004019786 Mar 2004 WO
2004034912 Apr 2004 WO
2004056273 Jul 2004 WO
2004086983 Oct 2004 WO
2004091442 Oct 2004 WO
2004098461 Nov 2004 WO
2005037132 Apr 2005 WO
2005087153 Sep 2005 WO
2005094741 Oct 2005 WO
2005110273 Nov 2005 WO
2005110274 Nov 2005 WO
2005112842 Dec 2005 WO
2005122954 Dec 2005 WO
2006040307 Apr 2006 WO
2006045042 Apr 2006 WO
2006046950 May 2006 WO
2006069078 Jun 2006 WO
2006081545 Aug 2006 WO
2006084165 Aug 2006 WO
2006084166 Aug 2006 WO
2006108145 Oct 2006 WO
2006108964 Oct 2006 WO
2007013465 Feb 2007 WO
2007059199 May 2007 WO
2007087190 Aug 2007 WO
2007097994 Aug 2007 WO
2007149348 Dec 2007 WO
2008065467 Jun 2008 WO
2009064866 May 2009 WO
Non-Patent Literature Citations (193)
Entry
Cook Medical, Needle Suspension Product Pages, <<http://www.cookmedical.com>>, last accessed Aug. 13, 2008.
Delorme, Emmanuel., “Transobturator urethral suspension: mini-invasive procedure in the treatment of stress urinary incontinence in women,” Progress in Urology, 11(6):1306-13, Dec. 2001.
Ghoniem, Gamal et al., “Modified Pubovaginal Sling and Martius Graft for Report of the Recurrent Vesicovaginal Fistula Involving the Internal Urinary Sphincter,” Eur Urol 1995; 27:241-245.
Gormley, E. Ann et al., “Pubovaginal slings for the management of urinary incontinence in female adolescents,” The Journal of Urology, vol. 152, pp. 822-825, Aug. 1994.
Kelly, Mark J. et al., “Symptom analysis of patients undergoing modified Pereyra bladder neck suspension for urinary stress incontinence,” Urology, vol. 37, No. 3, Mar. 1991.
Kersey, J., “The guaze hammock sling operation in the treatment of stress incontinence,” British Journal of Obstetrics and Gynaecology, vol. 90, pp. 945-949, Oct. 1983.
Kil, P.J.M. et al., “Transvaginal ultrasonography and urodynamic evaluation after suspension operations: comparison among the Gittes, Stamey and Burch suspensions,” The Journal of Urology, vol. 146, pp. 132-136, Jul. 1991.
Korman, Howard J. et al., “Success rate of modified Pereyra bladder neck suspension determined by outcomes analysis,” The Journal of Urology, vol. 152, pp. 1453-1457, Nov. 1994.
Parra, O. et al., “Experience with a Simplified Technique for the Treatment of Female Urinary Incontinence,” The British Journal of Urology (1990), 66, 615-617.
PCT/US07/78308 filed Sep. 12, 2007 International Search Report dated Jun. 5, 2008.
PCT/US07/78308 filed Sep. 12, 2007 Written Opinion dated Jun. 5, 2008.
Petros, Peter E. Papa et al., “The Combined Intravaginal Sling and Tuck Operation. An Ambulatory Procedure for Cure of Stress and Urge Incontinence,” Acta Obstet Gynecol Scan Suppl 153: 53, pp. 115-117, 1990.
Raz, Shlomo et al., “The Raz Bladder Neck Suspension: Results in 206 Patients,” The Journal of Urology, vol. 148, pp. 845-850, Sep. 1992.
Ulmsten, U. et al., “An Ambulatory Surgical Procedure Under Local Anesthesia for Treatment of Female Urinary Incontinence,” Int Urogynecol J (1996) 7:81-86.
Wahle, Gregory R. et al., “Vaginal Surgery for Stress Urinary Incontinence,” Urology, vol. 43, No. 4, pp. 416-419, Apr. 1994.
EP 06800736.8 filed Aug. 3, 2006 Search Report dated Apr. 26, 2010.
EP 06824802.0 filed Aug. 3, 2006 Search Report dated Dec. 13, 2010.
EP 06827826.6 filed May 14, 2008 Supplementary Search Report dated Feb. 4, 2011.
EP 06846828.9 filed Dec. 28, 2006 Office Action dated May 18, 2010.
EP 06846828.9 filed Dec. 28, 2006 Official Minutes dated Oct. 12, 2012.
EP 06846828.9 filed Dec. 28, 2006 Search Report dated Apr. 26, 2010.
EP 07753112.7 filed Mar. 15, 2007 Supplemental European Search Report dated Dec. 30, 2010.
Falconer, C., Ekman-Ordeberg, G., Malmstrom, A., Ulmsten, U.; “Clinical Outcome and Changes in Connective Tissue Metabolism After Intravaginal Slingplasty in Stress Incontinent Women”; The International Urogynecology Journal; vol. 7, pp. 133-137, 1996.
Falconer, C., Soderberg, M., Blomgren, B., Ulmsten, U.; “Influence of Different Sling Materials on Connective Tissue Metabolism in Stress Urinary Incontinent Women”; The International Urogynecology Journal; S19-S23, 2001.
Glowacki, CA, et al., “Bone anchors in urogynecology,” Clin Obstet Gynecol, Sep. 2000;43(3):659-69, Review.
Gomelsky, Alex, et al., “Biocompatibility Assessment of Synthetic Sling Materials for Female Stress Urinary Incontinence,” The Journal of Urology, Oct. 2007, vol. 178, pp. 1171-1181.
Horbach, Nicolette S.; “Suburethral Sling Procedures”; Urogynecology and Urodynamics Theory and Practice Fourth Edition; Chapter 42, pp. 569-579, 1996.
Image, <http://www.ivstunneller.com/images/anterior-procedure.jpg>printed on Jul. 10, 2006.
Image, www.obgyn.neUurogyn/articles/moore—cystocele , printed Jul. 10, 2006 and Mar. 10, 2011, <http://www.obgyn.neUurogyn/articles/moore—cystocele>.
Iosif, S., et al., “Urodynamic studies of women with prolapse and stress incontinence before and after surgical repair,” Urodynamics Studies, 101:1433-1442 (1979).
Jacquetin B., “Bladder suspension exclusively through the vagina: at last!” J Gynecol Obstet Biol Reprod 1991;20(8):1143-4, Paris.
Jacquetin B., “Genital prolapses. Diagnosis,” Rev Prat. Sep. 15, 2001;51(14):1609-16.
Jacquetin B., “Use of “TVT” in surgery for female urinary incontinence,” J Gynecol Obstet Biol Reprod, May 2000;29(3):242-7.
Johnson & Johnson (Article), “Gynecare Prolift Systems: ‘You Know Where You Want to Go . . . GPS for Pelvic Floor Repair,’” <http://www.jnjgateway.com/home.jhtml?loc=USENG&page=viewContent&contentId=09008b98>8102f39b&parentId=09008b988102f39b (2006).
Johnson & Johnson Gateway®, “Optimal technique for access to anatomic landmarks,” <http://www.jnjgateway.com/home.jhtml?loc=USENG&page=viewContent&contentID=090> (2005).
Johnson & Johnson Gateway®: Gynecare Prolift Innovative Design, http://www.jnjgateway.com/home.jhtml?loc=USENG&page=viewContent&contentID=090 (2005).
Johnson & Johnson Gateway®: Gynecare TVT Abdominal Approach, <http://www.jnjgateway.com/home.jhtml?loc=USENG&page.=vieewContent&contentID=090> (2005).
Johnson & Johnson Gateway®: Gynecare TVT Obturator System, “Tension-Free Support for Incontinence” <http://www.jnjgateway.com/home.jhtml?loc=USENG&page=viewContent&contentID=090> (2005).
Johnson & Johnson Gateway®: Vaginal Approach, <http://www.jnjgateway.com/home.jhtml?loc=USENG&page=viewContent&contentID=090> (2005).
JP 2008-525210 filed Feb. 1, 2008 Office Action dated Oct. 5, 2011.
JP 2008-525211 filed Feb. 1, 2008 Office Action dated Oct. 31, 2011.
JP 2008-525252 filed Aug. 3, 2006 Office Action dated Aug. 26, 2011.
JP 2008-525252 filed Aug. 3, 2006 Office Action dated May 11, 2012.
JP 2008-548841 filed Jun. 27, 2008 Office Action dated Jan. 19, 2012.
Karlovsky, Matthew E., et al., “Surgical Treatment of Stress Urinary Incontinence”, Journal of Urology, 2003.
Karmarkar, Santoshi J., et al., “The 3-loop technique: A reliable technique for anterior pubic fixation in bladder exstrophy,” The Journal of Urology, Sep. 1995 vol. 154, 1173-1176.
Karram, Mickey M ., Bhatia, Narender N.; “Patch procedure: Modified Transvaginal Fascia Lata Sling for recurrent or severe stress urinary incontinence”; Obstetrics and Gynecology, pp. 461-463, Mar. 1990.
Kobashi, Kathleen C., et al., “Erosion of Woven Polyester Pubovaginal Sling,” The Journal of Urology, Dec. 1999, vol. 162, pp. 2070-2072.
Korda, Andrew; Peat, Brian; Hunter, Peter; “Experience with Silastic Slings for Female Urinary Incontinence”; Aust NZ J Obstet Gynaecol, pp. 150-154, 1989.
Lichtenstein, Irving L, Shulman, Alex G., Amid, Parviz K., Montllor, Michele M.; “The Tension-Free Hernioplasty”; The American Journal of Surgery, vol. 157; Feb. 1989.
McIndoe, G.A.J., Jones, R.W., Grieve B.W.; “The Aldridge Sling Procedure in the Treatment of Urinary Stress Incontinence”; Aust NZ J Obstet Gynaecol; 1987.
MedlinePlus Medical Encyclopedia, “Female urinary tract,” http://www.nlm.nih.gov/medlineplus/ency/imagepages/1122.htm (2004).
Miklos et al., Laparoscopic Urogynecology Center of Atlanta—Dr. Miklos & Dr. Moore, “Laparoscopic and Minimally Invasive Procedures, ‘Tension Free Vaginal Tape (TVT) Sling’” printed Jul. 12, 2006; <http://www.urogynecologychannel.net/lap—proc12.php>.
Miklos et al., Vaginal prolapse relaxation and enterocele repair, printed Jul. 12, 2006; http://www.urogynecologychannel.net/prolapse6.php.
Miklos et al., Vaginal prolapse relaxation, posterior vaginal wall prolapse, printed Jul. 12, 2006; http://www.urogynecologychannel.net/prolapse3.php.
Miklos et al., Vaginal prolapse relaxation, uterine prolapse, printed Jul. 12, 2006; <http://www.urogynecologychannel.net/prolapse4.php>.
Miklos et al., Vaginal prolapse relaxation, uterosacral ligaments, printed Jul. 12, 2006; http://www.urogynecologychannel>.net/prolapse2a.php.
Miklos et al., Vaginal prolapse relaxation, vaginal vault prolapse, printed Jul. 12, 2006; <http://www.urogynecologychannel.net/prolapse5.php>.
Miklos et al., Vaginal relaxation, vaginal prolapse relaxaton, enterocele repair, Types of Vaginal Prolapse, printed on Jul. 12, 2006, http://www.urogyneocologychannel.net/prolapse.php?id=Prolapse.
Moore, Robert D., “Transobturator Approach for Cystocele Repair With Anterior Wall Mesh,” <http://www.obgyn.net/hysterectomy-alternatives/hysterectomy-alternatives.asp>? page=urogyn/articles/moore—cystocele (2006).
Morgan, J.E.; “A sling operation, using Marlex polypropylene mesh, for treatment of recurrent strss incontinence.” vol. 106, No. 3, pp. 369-377, Feb. 1970.
Mubiayi N., et al., “Surgical cure of stress urinary incontinence with vaginal tissue sling: technique, results, indications,” Prog Urol. Feb. 2002;12(1):60-9.
Narik, G., Palmrich, A.H.; “A simplified sling operation suitable for routine use”; American Journal of Obstetrics & Gynecology, vol. 84, No. 3, Aug. 1962.
Netterimages.com, “Cystocele, Urethrocele,” Image No. 5192, printed Jul. 24, 2006; <http://ww.netterimages.com/images/vpv/000/000/005/5192-05> . . . .
Netterimages.com, “Rectocele, Enterocele,” Image No. 5193, printed Jul. 24, 2006; <http://www.netterimages.com/image/5193.htm>.
Nguyen, JK, “Current concepts in the diagnosis and surgical repair of anterior vaginal prolapse due to paravaginal defects,” Obstet Gynecol Surv, Apr. 2001;56(4):239-46.
Nichols, David H.; “The Mersilene Mesh Gauze-Hammock for Severe Urinary Stress Incontinence”; Obstetrics and Gynecology; Obstetrics & Gynegology, vol. 41, No. 1, pp. 88-93, Jan. 1973.
Nickel, RF, et al, “Evaluation of a transpelvic sling procedure with and without colposuspension for treatment of female dogs with refractory urethral sphincter mechanism incompetence.” Vet Surg. Mar.-Apr. 1998;27(2):94-104.
Norris, Jeffrey P., Breslin, David S., Staskin, David R.; “Use of Synthetic Material in Sling Surgery: A Minimally Invasive Approach”, Journal of Endourology; vol. 10, No. 3, Jun. 1996.
O'Donnell, Pat D.; “Combined Raz Urethral Suspension and McGuire Pubovaginal Sling for Treatment of Complicated Stress Urinary Incontinence”; Journal of the Arkansas Medical Society, vol. 88, No. 8, pp. 389-392, Jan. 1992.
Okoshi, Takafumi, et al., “Long-term Results of a New Antithrombogenic Cardiac Wall Substitute,” Trans Am Soc. Artif Intern Organs, XXXV:391-395 (1989).
PCT/AU2000/001298 filed Oct. 20, 2000 International Preliminary Examination Report dated Jan. 29, 2002.
PCT/AU2000/001298 filed Oct. 20, 2000 Search Report dated Jan. 3, 2001.
PCT/US03/24212 filed Aug. 1, 2003 International Search Report dated May 28, 2004.
PCT/US03/24212 filed Aug. 1, 2003 Written Opinion dated Aug. 24, 2004.
PCT/US2003/013113 filed Apr. 28, 2003 International Preliminary Examination Report dated Oct. 14, 2004.
PCT/US2003/013113 filed Apr. 28, 2003 International Seach Report dated Oct. 15, 2003.
PCT/US2003/024212 filed Aug. 1, 2003 International Search Report dated May 24, 2004.
PCT/US2003/024212 filed Aug. 1, 2003 Written Opinion dated Aug. 24, 2004.
PCT/US2006/030369 filed Aug. 3, 2006 International Preliminary Report on Patentability dated Mar. 31, 2009.
PCT/US2006/030369 filed Aug. 3, 2006 Search Report dated Aug. 12, 2008.
PCT/US2006/030369 filed Aug. 3, 2006 Written Opinion dated Aug. 12, 2008.
PCT/US2006/030370 filed Aug. 3, 2006 International Preliminary Report on Patentability dated Feb. 4, 2008.
PCT/US2006/030370 filed Aug. 3, 2006 Search Report dated Jul. 20, 2007.
PCT/US2006/030370 filed Aug. 3, 2006 Written Opinion dated Jul. 20, 2007.
PCT/US2006/030581 filed Aug. 3, 2006 International Preliminary Report on Patentability dated Mar. 17, 2009.
PCT/US2006/030581 filed Aug. 3, 2006 Search Report dated Jul. 7, 2008.
PCT/US2006/030581 filed Aug. 3, 2006 Written Opinion dated Jul. 7, 2008.
PCT/US2006/044315 filed Nov. 14, 2006 International Preliminary Report on Patentability dated Mar. 24, 2009.
PCT/US2006/044315 filed Nov. 14, 2006 International Seach Report dated May 6, 2008.
PCT/US2006/044315 filed Nov. 14, 2006 Written Opinion dated May 6, 2008.
PCT/US2006/062639 filed Dec. 28, 2006 International Preliminary Report on Patentability dated Oct. 7, 2008.
PCT/US2006/062639 filed Dec. 28, 2006 Search Report dated Oct. 1, 2007.
PCT/US2006/062639 filed Dec. 28, 2006 Written Opinion dated Oct. 1, 2007.
PCT/US2007/006461 filed on Mar. 15, 2007 International Preliminary Report on Patentability dated Sep. 16, 2008.
PCT/US2007/006461 filed on Mar. 15, 2007 Search Report dated May 22, 2008.
PCT/US2007/006461 filed on Mar. 15, 2007 Written Opinion dated May 22, 2008.
PCT/US2008/083381 filed Nov. 13, 2008 International Search Report dated Dec. 29, 2008.
PCT/US2008/083381 filed Nov. 13, 2008 Written Opinion of the International Searching Authority dated Dec. 29, 2008.
Pelosi, Ma, et al., “The transobturator sling: newest tension-free suburethral sling for treatment of stress urinary incontinence,” Surg Technol Int. 2004;13:173-9. Review.
Petros, Peter E. Papa, “Ambulatory surgery for urinary incontinence and vaginal prolapse,” Med. J. of Australia, 161:171-172 (1994).
Raz, Shlomo; Female Urology; Second Edition; Selected Chapters, © 1996.
Ridley, John H.; “Appraisal of the Goebell-Frangenheim-Stoeckel sling procedure”; American Journal of Obstetrics & Gynecology, vol. 95, No. 5, pp. 714-721, Jul. 1966.
Scotti, RJ, et al., “Paravaginal repair of lateral vaginal wall defects by fixation to the ischial periosteum and obturator membrane,” Am J Obstet Gynecol. Dec. 1998;179(6 Pt 1):1436-45.
Shands Healthcare, “Bladder neck is elevated by stitching it and the urethra to anterior pubic bone,” Copyright 1997-2011, printed Nov. 3, 2010,<http://www.shands.org/health/imagepages/17202.htm>.
Silver, Richard I., et al., “Staged closure of the pelvis in cloacal exstrophy: first description of a new approach,” The Journal of Urology, Jan. 1999, vol. 161, pp. 263-266.
Stanton, Stuart L.; “Suprapubic Approaches for Stress Incontinence in Women”; Journal of the American Geriatrics Society, vol. 38, No. 3, pp. 348-351, Mar. 1990.
Staskin, David R., Choe, Jong M., Breslin, David S.; “The Gore-Tex sling procedure for female sphincteric incontinence: indications, technique, and results”; World J. Urol.; vol. 15, pp. 295-299, 1997.
Sussman, J.S., et al., “A Comparison of Methods of Repairing the Symphysis Pubis in Bladder Exstrophy by Tensile Testing,” Brit. J. Urol., 79: 979-984, 1997.
U.S. Appl. No. 10/633,254, filed Aug. 1, 2003 Advisory Action dated Aug. 26, 2008.
U.S. Appl. No. 10/633,254, filed Aug. 1, 2003 Decision on Appeal dated Jul. 20, 2011.
U.S. Appl. No. 10/633,254, filed Aug. 1, 2003 Final Office Action dated Jun. 18, 2008.
U.S. Appl. No. 10/633,254, filed Aug. 1, 2003 Non-Final Office Action dated Jan. 29, 2007.
U.S. Appl. No. 10/633,254, filed Aug. 1, 2003 Non-Final Office Action dated Nov. 15, 2005.
U.S. Appl. No. 10/633,254, filed Aug. 1, 2003 Non-Final Office Action dated Sep. 18, 2007.
U.S. Appl. No. 10/633,254, filed Aug. 1, 2003 Notice of Allowance dated Oct. 11, 2011.
U.S. Appl. No. 11/993,003, filed Jan. 22, 2008 Examiner's Answer dated Nov. 30, 2011.
U.S. Appl. No. 11/993,003, filed Jan. 22, 2008 Non-Final Office Action dated Jul. 20, 2011.
U.S. Appl. No. 11/993,089, filed Jun. 9, 2010 Non-Final Office Action dated Aug. 27, 2012.
U.S. Appl. No. 11/993,375, filed Feb. 6, 2009 Non-Final Office Action dated May 10, 2011.
U.S. Appl. No. 11/993,003, filed Jan. 22, 2008 Advisory Action dated Feb. 8, 2011.
U.S. Appl. No. 11/993,003, filed Jan. 22, 2008 Final Office Action dated Dec. 10, 2010.
U.S. Appl. No. 11/993,003, filed Jan. 22, 2008 Non-Final Office Action dated Jul. 14, 2010.
U.S. Appl. No. 12/093,493, filed Jul. 14, 2008 Final Office Action dated Jul. 6, 2011.
U.S. Appl. No. 12/093,493, filed Jul. 14, 2008 Non-Final Office Action dated Jan. 20, 2011.
U.S. Appl. No. 12/093,493, filed Jul. 14, 2008 Notice of Allowability dated Sep. 22, 2011.
U.S. Appl. No. 12/159,589, filed Aug. 15, 2008 Examiner's Answer dated Nov. 9, 2011.
U.S. Appl. No. 12/159,589, filed Aug. 15, 2008 Final Office Action dated May 12, 2011.
U.S. Appl. No. 12/159,589, filed Aug. 15, 2008 Non-Final Office Action dated Dec. 10, 2010.
U.S. Appl. No. 12/159,589, filed Aug. 15, 2008 Non-Final Office Action dated Jul. 12, 2010.
U.S. Appl. No. 12/159,589, filed Aug. 15, 2008 Notice of Panel Decision dated Aug. 29, 2011.
U.S. Appl. No. 12/269,749, filed Nov. 12, 2008 Non-Final Office Action dated Sep. 14, 2011.
U.S. Appl. No. 12/269,749, filed Nov. 12, 2008 Notice of Allowance dated Mar. 16, 2012.
U.S. Appl. No. 12/282,641, filed Dec. 4, 2008 Non-Final Office Action dated Dec. 8, 2011.
U.S. Appl. No. 12/282,641, filed Dec. 4, 2008 Non-Final Office Action dated Jul. 12, 2012.
Wall, LL, et al., Use of a pedicled rectus abdominus muscle flap sling in the treatment of complicated stress urinary incontinence. Am J Obstet Gynecol. Dec. 1996;175(6):1460-4; Discussion 1464-6.
Walters, Mark D., et al., “Anterior vaginal wall prolapse: Innovative surgical approaches,” Cleveland Clinic Journal of Medicine, Dec. 2005, 72:4 S20-S27.
Yan, A., et al, “Cystocele repair by a synthetic vaginal mesh secured anteriorly through the obturator foramen,” Eur J Obstet Gynecol Reprod Biol, Jul. 15, 2004;115(1):90-4.
Zimmern, Philippe, et al., “A prospective evaluation of four-corner bladder neck suspension for grade II/III cystocele repair,” Urodynamics Soc. Symp. Abstracts, p. 231 (1990).
AU 2006332514 filed Dec. 28, 2006 First Examiner's Report dated Oct. 4, 2011.
AU 2006332514 filed Dec. 28, 2006 Second Examiner's Report dated Jul. 5, 2012.
Bard (Article), “Avaulta™ BioSynthetic Support System,” http://www.crbard.com/news/innovations/Avaulta.cfm (2007).
Bard (Article), “AVAULT™ BioSynthetic Support System ‘Anterior and Posterior Posterior Pelvic Floor Defect Repair with the Avaulta™ Bio-synthetic Support system,’” http://www.bardmdu.com/products/loadProduct.aspx?prodID=280&bUnitID=3 (2007).
Bard (Article), “PelviLace® TO Trans-Obturator BioUrethral Support System,” http://www.bardurological.com/products/loadproduct.aspx?prodID=277 (2008).
Bard (Article), “URETEX® TO—Trans-Obturator Urethral Support System ‘Not all Mesh is created equal,’” Copyright 1997-2004, <http://www.bardurological.com/products/loadproductaspx?prodID=186>.
Bard Photo Library “Uretex® Mesh,” printed Jul. 12, 2006; http://www.bardurological.com/products/product—photoLibrary.aspx?prodID=185&photoID=269.
Bard Photo Library, “Avaulta™ Posterior BioSynthetic Support System”, Copyright 1997-2008; printed Oct. 23, 2008; http://www.bardurological.com/products/product—photoLibrary.aspx?prodID=281&photoID=326>.
Bard Photo Library, Uretex® Mesh in the Anatomy—printed Jul. 12, 2006 <http://www.bardurological.com/products/product—photoLibrary.aspx?prodID=185&photoID=270>.
Bard Photo Library, Hook Introducer 2 printed Jul. 12, 2006 <http://www.bardurological.com/products/product—photoLibrary.aspx?prodID=186&photoID=344>.
Bard Photo Library, Hook Introducer printed Jul. 12, 2006 http://www.bardurological.com/products/product—photoLibrary.aspx?prodID=186&photoID=343.
Bard Photo Library, Pelvic Diagram 1 (photo id 282) printed Jul. 12, 2006 http://www.bardurological.com/products/product—photoLibrary.aspx?prodID=186&photoID=282.
Bard Photo Library, Pelvic Diagram 2 (photo id 283) printed Jul. 12, 2006 http://www.bardurological.com/products/product—photoLibrary.aspx?prodID=186&photoID=283.
Bard Photo Library, Pelvic Diagram 3 (photo id 284) printed Jul. 12, 2006 http://www.bardurological.com/products/product—photoLibrary.aspx?prodID=186&photoID=284.
Bard Photo Library, Pelvic Diagram 4 (photo id 285) printed Jul. 12, 2006 http://www.bardurological.com/products/product—photoLibrary.aspx?prodID=186&photoID=285.
Bard Photo Library, Surgical Technique (photo id 336) printed Jul. 12, 2006 http://www.bardurological.com/products/product—photoLibrary.aspx?prodID=186&photoID=336.
Bard Photo Library, Surgical Techniques (photo id 337) printed on Jul. 12, 2006 http://www.bardurological.com/products/product—photoLibrary.aspx?prodID=186&photoID=337.
Bard Photo Library, Surgical Techniques (photo id 338) printed Jul. 12, 2006 http://www.bardurological.com/products/product—photoLibrary.aspx?prodID=186&photoID=338.
Bard Photo Library, Surgical Techniques (photo id 339) printed Jul. 12, 2006 http://www.bardurological.com/products/product—photoLibrary.aspx?prodID=186&photoID=339.
Bard Photo Library, Surgical Techniques (photo id 340) printed Jul. 12, 2006 http://www.bardurological.com/products/product—photoLibrary.aspx?prodID=186&photoID=340.
Bard Photo Library, Surgical Techniques (photo id 341) printed Jul. 12, 2006 http://www.bardurological.com/products/product—photoLibrary.aspx?prodID=186&photoID=341.
Bard Photo Library, Surgical Techniques (photo id 345) printed Jul. 12, 2006 http://www.bardurological.com/products/product—photoLibrary.aspx?prodID=186&photoID=345.
Bard Photo Library, Uretex T.O. Transobturator Urethral Support System printed Jul. 12, 2006 <http://www.bardurological.com/products/product—photoLibrary.aspx?prodID=186&photoID=266>.
Bard Photo Library, Uretex® TO Trans-Obturator Urethral Support System dated Oct. 23, 2008<http://www.bardurological.com/products/product—photoLibrary.aspx?prodID=186&photoID=204&bUnitID=2>.
Bard Photo Library, Urethral Mesh printed Jul. 12, 2006 <http://www.bardurological.com/products/product—photoLibrary.aspx?prodID=185&photoID=271>.
Bard, “Avaulta™ Anterior BioSynthetic Support System,” Copyright 2006-2011, http://www.bardnordic.com/main/product.asp?.sectionTypeID=2&sectionID=6&productID=247.
Bard, “Uretex® Self-Anchoring Urethral Support System—FAQ,” printed Jul. 12, 2006; <http://www.bardurological.com/products/product—faq.aspx?prodID=185>.
Bryans, Fred E. “Marlex gauze hammock sling operation with Cooper's ligament attachment in the management of recurrent urinary stress incontinence.” American Journal of Obstetrics and Gynecology, vol. 133, No. 3, Feb. 1979.
Burch, John C., “Urethrovaginal fixation to Cooper's ligament for correction of stress incontinence, cystocele, and prolapse,” Am. J. Obst. & Gyne, 281-290 (1961).
Burch, John C.; “Urethrovaginal fixation to Cooper's ligament for correction of stress incontinence, cystocele, and prolapse.” American Journal of Obstetrics & Gynecology, vol. 31, No. 2, Feb. 1961, pp. 281-290.
Choe, JM, “Preventing urethral obstruction using the 6-point fixation and weight-adjusted spacing nomogram during sling surgery,” Int Urogynecol J Pelvic Floor Dysfunct, 2001;12(2):122-8.
Choe, Jong M., Staskin, David R.; “Gore-Tex Patch Sling: 7 Years Later”; Adult Urology, 54(4), pp. 641-646, 1999.
CN 200880115957.3 filed May 12, 2010 Office Action dated Apr. 28, 2012.
Collinet, P., et al., “Cure de cystocele par plastron vaginal,” J Gynecol Obstet Biol Reprod, 29:197-201 (2000).
Cook; Urogynecology; Product Technical Datasheet and Order form. 1996.
Cosson, M., et al., “Cure of cystocele with vaginal patch,” Prog Urol. Apr. 2001;11(2):340-6.
Cosson, M., et al., “The vaginal patch plastron for vaginal cure of cystocele. Preliminary results for 47 patients,” Eur J Obstet Gynecol Reprod Giol. Mar. 2001;95(1):73-80.
Cosson, Michel, et al., “Cure de cystocele par plastron vaginal,” Progres en Urologie, 11:340-346 (2001).
Cruikshank, Stephen H., et al., “Anterior vaginal wall culdeplasty at vaginal hysterectomy to prevent posthysterectomy anterior vaginal wall prolapse,” Am. J. Obstet. Gynecol., 1863-1872 (1996).
De Leval J., “Novel surgical technique for the treatment of female stress urinary incontinence: transobturator vaginal tape inside-out,” Eur Urol. Dec. 2003;44(6):724-30.
Delorme, E., “Transobturator urethral suspension: mini-invasive procedure in the treatment of stress urinary incontinence in women,” Prog Urol. Dec. 2001;11(6):1306-13.
Delorme, E., et al., “Transobturator tape (Uratape). A new minimally invasive method in the treatment of urinary incontinence in women,” Prog Urol. Sep. 2003;13(4):656-9.
Di Benedetto, V., et al., “Transurethral Puncture of Ureterocele Associated With Single Collecting System in Neonates,” J. Ped. Surg., 32: 1325-1327, 1997.
Dmochowski et al., “Biocompatibility Assessment of Synthetic Sling Materials for Female Stress Urinary Incontinence,” The Journal of Urology, vol. 178, Issue 4, pp. 1171-1181, Oct. 2007.
Dmochowski et al., “Erosion of Woven Polyester Pubovaginal Sling,” The Journal of Urology, vol. 162, Issue 6, pp. 2070-2072, Dec. 1999.
Dmochowski, R., et al., “The Protegen Sling for the Treatment of Female Stress Urinary Incontinence,” J. Urol., http://home.satx.rr.com/sgsu/usurg/protegen.html (1997).
Eglin, G., et al., “Transobturator subvesical mesh. Tolerance and short-term results of a 103 case continuous series,” Gynecology Obstetrique & Fertilite, Jan. 2003;31(1):14-19(6).
EP 03751825.5 Supplementary European Search Report dated Jun. 19, 2009.
EP 06789465.9 filed Aug. 3, 2006 Search Report dated Apr. 28, 2010.
EP 06800736.8 filed Aug. 3, 2006 Examination Report dated Feb. 24, 2012.
EP 08849041.2 extended European Search Report dated Mar. 12, 2013.
MX/a/2010/005271 Office Action dated Mar. 7, 2013.
U.S. Appl. No. 13/524,408, filed Jun. 15, 2012 Non-Final Office Action dated Mar. 7, 2013.
Walters, Mark D., Percutaneous Suburethral Slings: State of the Art, presented at the conference of the American Urogynecologic Society, Chicago (Oct. 2001).
Related Publications (1)
Number Date Country
20100234681 A1 Sep 2010 US
Provisional Applications (2)
Number Date Country
60825417 Sep 2006 US
60922745 Apr 2007 US